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Summary 
Honey bee virus research is an enormously broad area, ranging from subcellular molecular biology through physiology and behaviour, to 
individual and colony-level symptoms, transmission and epidemiology. The research methods used in virology are therefore equally diverse. 
This article covers those methods that are very particular to virological research in bees, with numerous cross-referrals to other BEEBOOK 
papers on more general methods, used in virology as well as other research. At the root of these methods is the realization that viruses at 
their most primary level inhabit a molecular, subcellular world, which they manipulate and interact with, to produce all higher order 
phenomena associated with virus infection and disease. Secondly, that viruses operate in an exponential world, while the host operates in a 
linear world and that much of the understanding and management of viruses hinges on reconciling these fundamental mathematical 
differences between virus and host. The article concentrates heavily on virus propagation and methods for detection, with minor excursions 
into surveying, sampling management and background information on the many viruses found in bees.  
 
Métodos estándar para la investigación de virus en Apis mellifera 
Resumen  
La investigación de los virus de la abeja de la miel es un área sumamente amplia, que abarca desde la biología molecular subcelular hasta la 
fisiología y el comportamiento, desde síntomas al nivel de individuo hasta al nivel de la colmena, transmisión y epidemiología. Los métodos de 
investigación en virología son, por tanto, diversos. Este artículo incluye aquellos métodos específicos de la investigación virológica en las 
abejas, con numerosas referencias cruzadas con otros artículos del BEEBOOK y otros más generales, usados tanto en virología como en otras 
disciplinas. La base de estos métodos es la comprensión de los virus en su nivel primario de hábitat molecular, ambiente subcelular, que 
manipulan y con el que interactúan, para producir otros fenómenos de orden superior asociados a la infección del virus y la enfermedad. En 
segundo lugar, estos virus actúan en un mundo exponencial, mientras que los hospedadores actúan en un mundo lineal y gran parte del 
entendimiento y manejo de los virus depende de los fundamentos matemáticos de las diferencias entre el virus y el hospedador. El artículo se 
centra principalmente en la propagación de virus y en los métodos para su detección, con inclusiones menores en su estudio, el manejo del 
muestreo y la información general sobre los numerosos virus que se encuentran en las abejas.  
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西方蜜蜂病毒研究的标准方法 
摘要 
蜜蜂病毒研究是一个非常广阔的领域，涉及亚细胞分子生物学、生理学和行为学、个体和蜂群症状、传播和流行病学。因此病毒学研究中用到的
方法种类繁多。本文涵盖了蜜蜂病毒学研究中特有的一些方法。其中涉及大量在病毒学和其它研究中都有用到的方法，在BEEBOOK关于普通方
法的章节中已有介绍。这些方法的根源是认识到病毒归根到底生活于一个分子和亚细胞世界，它们操控和作用于这一环境，以产生和病毒感染与
疾病相关的更高级别的现象。其次，病毒在指数世界运行，而宿主在线性世界运行，理解和控制病毒很大程度上依赖于协调病毒和宿主之间的这
些基本数学差异。本文重点针对病毒复制和病毒检测方法，也提及调查、取样操作及蜜蜂上发现的一些病毒的背景信息。  
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1. Introduction 
1.1. Honey bee viruses 
There are currently about 24 viruses identified in honey bees, whose 
physical and biological properties are described in Table 1 and Table 2 
respectively. Most of these were discovered by Bill Bailey, Brenda Ball 
and colleagues at Rothamsted Experimental Station, UK during the 
1960s-1980s (Bailey and Ball, 1991; Ribière et al., 2008). More recent 
additions have come mostly from mass sequencing of RNA and DNA 
from whole bee extracts (Fujiyuki et al., 2004; Cox-Foster et al., 
2007; Cornman et al., 2010; Runckel et al., 2011), and it may well be 
that there is overlap between the traditionally described viruses and 
these newly described viral sequences. Several viruses are also closely 
enough related to be regarded as members of a single species 
complex (DWV/VDV-1/EBV; ABPV/KBV/IAPV; SBV/TSBV; BVX/BVY and 
LSV-1/LSV-2), reducing the total to around 16-18 truly unique viruses.  
Although some viruses produce recognizable symptoms at 
sufficiently elevated titres, honey bee viruses generally persist 
naturally in honey bee populations at low levels, without causing overt 
symptoms, using a variety of transmission routes (Fig. 1; Table 2). 
Symptoms are, however, still the principal method by which diseases 
are diagnosed in the apiary. The advantages of symptom-based 
diagnosis are that it is robust, simple, fast and cheap and for some 
diseases accurate. The major disadvantages are that: 
 many virus infections do not present visible symptoms at all 
times 
 not all life stages present symptoms 
 often different viruses produce similar symptoms  
           (e.g. paralysis)  
 a single virus may present different symptoms (e.g. CBPV) 
 symptoms can be confounded if multiple virus infections are 
present 
All viruses are asymptomatic at lower levels of infection and most 
shorten the life span of bees to varying degrees. The diagnostic 
symptoms for the major virus diseases have been described in detail 
by Bailey and Ball (1991) and can be summarized as follows: 
 
1.1.1. Acute bee paralysis virus /Kashmir bee virus /Israeli 
acute paralysis virus 
Acute bee paralysis virus (ABPV), Kashmir bee virus (KBV) and Israeli 
acute paralysis virus (IAPV) are three closely related viruses (de Miranda 
et al., 2010a) that are largely symptomless, but they can be lethal at 
individual and colony level (Allen and Ball, 1995; Todd et al., 2007), 
particularly when transmitted by Varroa destructor (Ball, 1985; 1989; 
Ball and Allen, 1988) which is an active vector of these viruses (Chen 
et al., 2004a; Shen et al., 2005a; 2005b; DiPrisco et al., 2011). These 
viruses are characterized by the ability to kill both pupae (after 
injection; Bailey, 1967; Bailey and Ball, 1991) and adult bees (after 
injection or feeding: Maori et al., 2007a; 2009; Hunter et al., 2010) 
5 
very rapidly; 3-5 days after inoculation with sufficient virion loads. 
This exerts a strong negative selection pressure on the transmission 
by varroa, since infected pupae fail to complete development, 
preventing the release of infectious mites from the pupal cells 
(Sumpter and Martin, 2004). The association of these viruses with 
varroa infestation is therefore unstable and much influenced by the 
presence of other viruses that are better adapted to transmission by 
varroa.   
 
1.1.2. Black queen cell virus 
The main symptoms for black queen cell virus (BQCV) consist of 
blackened cell walls of sealed queen cells, containing dead pro-pupae 
(Bailey and Ball, 1991; Leat et al., 2000). Diseased larvae have a pale 
yellow appearance and tough sac-like skin, much like sacbrood. The 
virus is present in adult bees but without obvious symptoms. 
 
1.1.3. Aphid lethal paralysis virus & Big Sioux River virus 
Aphid lethal paralysis virus (ALPV) is a common intestinal dicistrovirus 
of several major agricultural aphid pests, associated with aphid 
population declines (van Munster et al., 2002 Laubscher and von 
Wechmar, 1992; 1993). Big Sioux River virus (BSRV) is closely related 
to Rhopalosiphum padi virus (RhPV; Moon et al., 1998), another 
common intestinal Dicistrovirus that uses the plant vascular system to 
transmit horizontally between aphids (Gildow and D’Arcy, 1990). Both 
can be detected infrequently at very low background levels in adult 
honey bees throughout the year, with a sharp quantitative increase 
during late summer (Runckel et al., 2011) when bees often feed on 
honeydew (aphid excreta) during low nectar flows. It is unclear 
therefore whether these viruses are incidental or truly infectious in 
bees. Either of these may be related to Berkeley bee picorna-like virus 
(BBPV; Lommel et al., 1985), which has not yet been sequenced.   
 
1.1.4. Deformed wing virus /kakugo virus /Varroa destructor 
virus-1 /Egypt bee virus 
The symptoms for deformed wing virus (DWV) consist of bees with 
crumpled and/or vestigial wings and bloated abdomen and infected 
bees die soon after emergence. Asymptomatic bees can also be 
heavily infected, though with lower titres than symptomatic bees 
(Bowen-Walker et al., 1999; Lanzi et al., 2006; Tentcheva et al., 
2006). The virus is detected in all other life stages as well, but without 
obvious symptoms (Chen et al., 2005a; 2005b; Yue and Genersch 
2005; Lanzi et al., 2006; Tentcheva et al., 2006; Fievet et al., 2006; 
Yue et al., 2006; de Miranda and Genersch, 2010). ‘kakugo’ virus (KV; 
Fujiyuki et al., 2004; 2006) and other strains of DWV (Terio et al., 
2008) have been associated with elevated aggression in bees, 
although naturally aggressive bee races are not more infected with 
DWV than gentle bee races (Rortais et al., 2006). DWV also affects 
sensory response, learning and memory in adults (Iqbal and Müller, 
2007).  
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Fig. 1. Diagram describing the different possible transmission routes for honey bee viruses. Adapted from de Miranda et al. (2011).  
Table 1. Summary of the physical properties, such as particle shape, size, capsid protein profile, genome type and length and taxonomy, of 
the currently known honey bee viruses. Adapted from Bailey and Ball (1991). 
 PHYSICAL PROPERTIES 
VIRUS SHAPE SIZE 
CAPSID  
PROTEINS 
NUCLEIC ACID GENOME SIZE TAXONOMY 
Acute bee paralysis virus ABPV icosahedral 30nm 35-9-33-24kDa ssRNA ~9.5kb Dicistroviridae 
Kashmir bee virus KBV icosahedral 30nm 37-6-34-25kDa ssRNA ~9.5kb Dicistroviridae 
Israeli acute  
paralysis virus 
IAPV icosahedral 30nm 35-7-33-26kDa ssRNA ~9.5kb Dicistroviridae 
Black queen cell virus BQCV icosahedral 30nm 31-14-29-30kDa ssRNA ~9.5kb Dicistroviridae 
Aphid lethal  
paralysis virus 
ALPV icosahedral 30nm 25-7-32-28kDa* ssRNA ~10kb Dicistroviridae 
Big Sioux River virus BSRV icosahedral 30nm 28-5-29-30kDa ssRNA ~10kb Dicistroviridae 
Deformed wing virus DWV icosahedral 30nm 32-2-44-28kDa ssRNA ~10kb Iflaviridae 
Varroa destructor virus-1 VDV-1 icosahedral 30nm 32-2-46-28kDa ssRNA ~10kb Iflaviridae 
Egypt bee virus EBV icosahedral 30nm 30-2-41-25kDa ssRNA ? Iflaviridae 
Sacbrood virus SBV icosahedral 30nm 31-2-32-30kDa ssRNA ~9kb Iflaviridae 
Thai/Chinese  
sacbrood virus 
TSBV icosahedral 30nm 31-2-32-30kDa ssRNA ~9kb Iflaviridae 
Slow bee paralysis virus SBPV icosahedral 30nm 27-2-46-29kDa ssRNA ~9.5kb Iflaviridae 
Chronic bee  
aralysis virus 
CBPV anisometric 30~60nm 23-(30/50/75?)kDa ssRNA ~2.3kb/~3.7kb unclassified 
Chronic bee paralysis 
satellite virus 
CBPSV icosahedral 17nm 15kDa ssRNA (3x)~1.1kb satellite 
Cloudy wing virus CWV icosahedral 17nm 19kDa ssRNA ~1.4kb ? 
Bee virus-X BVX icosahedral 35nm 52kDa ssRNA ? ? 
Bee virus-Y BVY icosahedral 35nm 50kDa ssRNA ? ? 
Lake Sinai Virus-1 LSV-1 ? ? 63kDa* ssRNA ~5.5kb unclassified 
Lake Sinai Virus-2 LSV-2 ? ? 57kDa* ssRNA ~5.5kb unclassified 
Arkansas bee virus ABV icosahedral 30nm 43kDa ssRNA ~5.6kb ? 
Berkeley bee  
picorna-like virus 
BBPV icosahedral 30nm 37-?-35-32kDa ssRNA ~9kb ? 
Varroa destructor  
Macula-like virus 
VdMLV icosahedral 30nm 24kDa* ssRNA ~7kb Tymoviridae 
Apis mellifera  
filamentous virus 
AmFV rod 150x450nm 12x(13~70kDa) dsDNA ? Baculoviridae 
Apis iridescent virus AIV polyhedral 150nm ? dsDNA ? Iridoviridae 
    *   (genome predicted) SDS-PAGE (order in polyprotein) 
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Table 2. Summary of the current state of knowledge concerning biological properties of honey bee viruses, such as transmission routes,  
associations with other parasites/pathogens, principal life stages affected and seasonal incidences. Adapted from de Miranda et al. (2011). 
  
TRANSMISSION 
ASSOCIATION  
LIFE STAGE  
SEASON  
HORIZONTAL VERTICAL INFECT/SYMPTOMS 
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O
R
A
L
-F
E
C
A
L
  
C
O
N
T
A
C
T
  
A
IR
  
V
A
R
R
O
A
 
O
V
A
R
IE
S
 
S
E
M
E
N
 
S
P
E
R
M
 
V
A
R
R
O
A
 
A
C
A
R
A
P
IS
 
N
O
S
E
M
A
 
M
A
L
P
IG
H
A
M
O
E
B
A
 
E
G
G
S
  
L
A
R
V
A
E
  
P
U
P
A
E
  
A
D
U
L
T
S
  
S
P
R
IN
G
  
S
U
M
M
E
R
  
A
U
T
U
M
N
  
Acute bee 
paralysis virus 
ABPV + - ? + + + ? + ? ? ? +/- +/- +/~ +/+ + +++ ++ 
Kashmir bee 
virus 
KBV + - ? + + ~ ? + ? ? ? +/- +/- +/+ +/+ + ++ +++ 
Israeli acute 
paralysis virus 
IAPV + - ? + + ~ ? + ? ? ? +/- +/- +/~ +/+ + ++ ++ 
Black queen 
cell virus 
BQCV + - ? ~ + ? ? + ? + ? +/- +/- +/+ +/- + +++ + 
Aphid lethal 
paralysis virus 
ALPV ? ? ? ? ? ? ? ? ? ? ? ?/? ?/? -/- +/? - +++ - 
Big Sioux River 
virus 
BSRV ? ? ? ? ? ? ? ? ? ? ? ?/? ?/? -/- +/? - +++ ++ 
Deformed wing 
virus 
DWV + - ? + + + ? + ? ? ? +/- +/- +/+ +/+ + ++ +++ 
Varroa  
destructor virus-1 
VDV-1 + - ? + + + ? + ? ? ? +/- +/- +/+ +/+ + ++ +++ 
Egypt bee virus EBV ? ? ? ? ? ? ? ? ? ? ? ?/? ?/? +/? +/~ ? ? ? 
Sacbrood virus SBV + - ? - ? ? ? ~ ? ? ? ?/? +/+ +/- +/~ +++ ++ + 
Thai/Chinese 
sacbrood virus 
TSBV + ? ? ? ? ? ? ? ? ? ? ?/? +/+ +/- +/~ ? ? ? 
Slow bee  
paralysis virus 
SBPV + - ? + ? ? ? + ? ? ? ?/? +/- +/- +/+ + + + 
Chronic bee 
paralysis virus 
CBPV + + ? - ? ? ? ~ ~ ? ? ~/- +/- +/- +/+ ++ ++ + 
Chronic bee 
paralysis 
satellite virus 
CBPSV ? ? ? ? ? ? ? ? ? ? ? ?/? ?/? ?/? +/? + + + 
Cloudy wing 
virus 
CWV ? ~ ~ - ? ? ? ~ ? ? ? -/- ~/- ~/- +/+ + + + 
Bee virus-X BVX + ? ? ? ? ? ? ? ? - + -/- -/- -/- +/+ +++ + + 
Bee virus-Y BVY + ? ? ? ? ? ? ? ? + - -/- -/- -/- +/+ + +++ + 
Lake Sinai 
Virus-1 
LSV-1 ? ? ? ? ? ? ? ? ? ? ? ?/? ?/? +/? +/? ++ +++ ++ 
Lake Sinai 
Virus-2 
LSV-2 ? ? ? ? ? ? ? ? ? ? ? ?/? ?/? ~/? +/? +++ + + 
Arkansas bee 
virus 
ABV ? ? ? ? ? ? ? ? ? ? ? ?/? ?/? ~/? +/? ? ? ? 
Berkeley bee 
picorna-like 
virus 
BBPV ? ? ? ? ? ? ? ? ? ? ? ?/? ?/? ?/? +/? ? ? ? 
Varroa destructor 
Macula-like 
virus 
VdMLV ? ? ? + ? ? ? + ? ? ? ?/? ?/? +/? +/? + ++ +++ 
Apis mellifera 
filamentous 
virus 
AmFV + ? ? ? ? ? ? ? ? + ? -/- -/- -/- +/+ +++ + + 
Apis iridescent 
virus 
AIV ? ? ~ ? ? ? ? ? ? ? ? -/- -/- -/- +/+ + ++ + 
    + (present)     ~ (uncertain) ? (unknown) 
Varroa destructor virus-1 (VDV-1) is genetically closely related to DWV 
but is reported to be more specific to Varroa destructor than to bees 
(Ongus, 2006). However, both viruses replicate in varroa mites as well 
as in honey bees (Ongus et al., 2004; Yue and Genersch, 2005; Zioni 
et al., 2011); both have been detected at high titres in different honey 
bee tissues (Zioni et al., 2011; Gauthier et al., 2011); both have been 
found in regions where V. destructor is absent (Martin et al., 2012) 
and natural recombinants between them have been found (Moore et 
al., 2011). VDV-1 and DWV therefore appear to co-exist in bees and 
mites as part of the same species-complex (de Miranda and Genersch, 
2010; Moore et al., 2011; Gauthier et al., 2011; Martin et al., 2012). 
Egypt bee virus (EBV) is serologically related to DWV, but has no 
known symptoms in adults, pupae or larvae (Bailey et al., 1979). 
 
1.1.5. Sacbrood virus /Thai sacbrood virus 
The clearest symptoms of sacbrood virus (SBV) appear a few days 
after capping, and consist of non-pupated pale yellow larvae, 
stretched on their backs with heads lifted up towards the cell opening, 
trapped in the unshed, saclike larval skin containing a clear, yellow- 
brown liquid. The virus is also present in adult bees, but without 
symptoms (Lee and Furgula, 1967; Bailey, 1968). Diseased larvae are 
most commonly seen in spring, but the disease normally clears quickly 
with rapid expansion. However, the Asian honey bee, Apis cerana, 
frequently suffers from lethal sacbrood epidemics caused by a closely 
related strain of SBV, variously called Thai sacbrood virus (TSBV), 
Chinese sacbrood virus (CSBV) or Korean sacbrood. The genetic 
differences of these strains with the SBV infecting A. mellifera are 
minimal. SBV-infected adults cease to attend brood or eat pollen, start 
foraging much sooner than normal, and only forage nectar, rarely 
pollen (Bailey and Fernando, 1972). These may be behavioural 
adaptations by A. mellifera to prevent sacbrood epidemics, since SBV 
is shed in the hypopharyngeal secretions fed to larvae and combined 
with pollen to make bee-bread (Bailey and Ball, 1991).   
 
1.1.6. Slow bee paralysis virus 
Slow bee paralysis virus (SBPV) is characterised by the paralysis of the 
front two pairs of legs of adult bees, a few days before dying, after 
inoculation by injection (Bailey and Woods, 1974). The virus is associated 
with, and transmitted by, V. destructor (Bailey and Ball, 1991; Denholm, 
1999). Despite this association, SBPV is rarely detected in bee colonies 
(Bailey and Ball, 1991; de Miranda et al., 2010b). SBPV can also be 
detected in larvae and pupae, but produces no symptoms in these. 
 
1.1.7. Chronic bee paralysis virus /satellite virus 
Chronic bee paralysis virus (CBPV) manifests itself in adult bees 
through two distinct set of symptoms. One set consists of trembling of 
the wings and bodies and a failure to fly, causing them to crawl in 
front of the hive in large masses. They often have partly spread, 
dislocated wings and bloated bodies as well. The other set of 
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symptoms consists of hairless, greasy black bees caused by nibbling 
attacks from healthy bees in the colony. They soon also become 
flightless, tremble and die (Bailey, 1965; Bailey and Ball, 1991; Ribière 
et al., 2010). The virus also infects the larval and pupal stages, can be 
detected in faecal material and is efficiently transmitted through 
contact and feeding (Bailey et al., 1983b; Ribière et al., 2010). CBPV 
is sometimes associated with a small “satellite” virus; chronic paralysis 
satellite virus (CBPSV; originally called chronic bee paralysis virus 
associate CBPVA), which has a unique genome and capsid protein to 
CBPV (Ribière et al., 2010) and is of unknown significance to 
symptomatology (Bailey et al., 1980; Ball et al., 1985).  
 
1.1.8. Cloudy wing virus 
The symptoms for cloudy wing virus (CWV) consist of opaque wings 
of severely infected adult bees, with lower titres resulting in asymptomatic 
infected bees (Bailey et al., 1980; Bailey and Ball, 1991; Carreck et al., 
2010). It cannot be propagated in larvae or pupae. It has an unpredictable 
incidence, no regular associations with other pathogens or pests. Like 
chronic bee paralysis satellite virus it has a small particle and very 
small genome, but they are serologically unrelated and their single 
capsid proteins are of different size (Table 1; Bailey et al., 1980).  
 
1.1.9. Bee virus X /Bee virus Y 
Bee virus X (BVX) is largely symptomless in adult bees and does not 
multiply in larvae or pupae (Bailey and Ball, 1991). It is associated 
with the protozoan Malpighamoeba mellificae that causes dysentery in 
winter bees (Bailey et al., 1983a). Bee virus Y (BVY) is serologically 
related to BVX and is similarly symptomless in adult bees, larvae or 
pupae. It is associated in adult bees with the dysentery inducing 
microsporidium Nosema apis (Bailey et al., 1983a). Both viruses are 
common, BVY more so than BVX, with strong peaks in late winter for 
BVX and early summer for BVY (Table 2; Bailey and Ball, 1991).   
 
1.1.10. Lake Sinai virus-1 /Lake Sinai virus-2 
Lake Sinai virus-1 (LSV-1) and Lake Sinai virus-2 (LSV-2) are two 
closely related viruses that were identified in through a mass 
metagenomic sequencing survey of honey bee colonies in the USA 
(Runckel et al., 2011). Their genome organization and sequences 
place them together with CBPV, in a unique family somewhere 
between the Nodaviridae and Tombusviridae. Both viruses are common 
and very abundant at peak incidence. LSV-1 is more common than 
LSV-2, present throughout the year with a peak in early summer. LSV-
2 has a very sharp incidence and abundance peak in late winter with 
low incidence and abundance the rest of the year. These viruses have 
also been detected, with similar incidences and titres, in historical 
European honey bee samples. LSV-1 and LSV-2 have strong similarities 
in capsid and genome size, seasonal incidence, predominantly adult-
based infection and absence of overt symptoms with Bee virus Y and 
Bee virus X respectively (Table 1 and 2), and may therefore be related. 
Virulence is usually correlated to the pathogen’s capacity to 
multiply in the host (Casadevall and Pirofski, 2001) 
represented, for example, by the virion titre when symptoms 
appear (Figure 2) or the rate of multiplication. It can also be 
affected by host and environmental factors, such as the 
transmission route or type of tissue/life-stage infected. For 
example, a pathogen may be virulent when infecting one type 
of tissue and non-virulent when infecting a different tissue 
(Casadevall and Pirofski, 1999). Virulence is therefore 
dependent on the nature of the infection. 
Virulence is also a relative trait, referring to the differences in 
the degree of pathology caused by strains of the same 
pathogen, or differences in the efficiency with which different 
strains can cause symptoms (Pirofski and Casadevall, 2012). 
For example, a pathogen strain that requires few particles to 
produce disease symptoms (strain-A in Figure 2) would be 
more virulent than a strain that requires many particles to 
produce the same symptoms (strain-B in Figure 2).  
Since virulence is a quantitative measure, methods have been 
developed to quantify the relative contributions of different 
virulence factors to a phenotype (McClelland et al., 2006).  
 Transmissibility: This refers to the efficiency with which a 
pathogen is transmitted to naïve hosts. There are valid 
arguments that at epidemiological level, transmissibility could 
be considered a component of virulence (Figure 2). The 
relationship between transmission and virulence is a major 
topic in pathogen-host evolutionary theory (e.g. Ebert and 
Bull, 2003) and has been discussed within the context of 
honey bee colony structure (Fries and Camazine, 2001) and 
honey bee virus transmission (de Miranda and Genersch, 2010). 
Fig. 2. Diagram describing the Log-linear relationship between virus 
concentration (X-axis) and virulence (Y-axis), represented by the  
degree/probability of Pathology (PPathology) or the efficiency/probability 
of Transmission (PTransmission). Other variables can also be plotted on 
the Y-axis.                                                Image © J R de Miranda.   
1.1.11. Arkansas bee virus & Berkeley bee virus 
Arkansas bee virus (ABV) and Berkeley bee picorna-like virus (BBPV) 
are two viruses first identified in the USA (Bailey and Woods, 1974; 
Lommel et al., 1985; Bailey and Ball, 1991) of which very little is 
known other than that they often occur together. They have no 
known symptoms in adult bees or brood. BBPV has typical capsid and 
genome size characteristics of the Dicistro- and Iflaviruses. 
 
1.1.12. Apis mellifera filamentous virus 
Apis mellifera filamentous virus (AmFV) is a baculovirus-like DNA virus 
that has no physical symptoms. It renders the haemolymph of adult 
bees milky white with rod-shaped viral particles, when examined by 
electron microscopy (Clark, 1978; Bailey and Ball, 1991). 
 
1.1.13. Apis iridescent virus 
The symptoms for Apis iridescent virus (AIV) are similar to the adult 
flightless clustering symptoms of CBPV (Bailey et al., 1976; Bailey and 
Ball, 1978). It is only known to occur in adult bees. A partial sequence 
of AIV has been published (Webby and Kalmakoff, 1999).  
 
1.2. Definitions: pathogenicity vs virulence; 
incidence vs prevalence 
The terms ‘Infectivity’, ‘Pathogenicity’, ‘Virulence’ and ‘Transmissibility’ 
are often used interchangeably, which has led to efforts to tighten 
and standardize their definition and adapt them to our improved 
understanding of host-pathogen interactions (Casadevall and Pirofski, 
1999; 2001). The same is true for the terms ‘Incidence’ and 
‘Prevalence’ in surveys and epidemiology. Here are their definitions:  
 Prevalence: The proportion of a population that is infected, or 
diseased, at any one time. 
 Incidence: This is the risk of new infection during a specified 
time. It is globally related to prevalence as a function of time: 
prevalence = incidence x time 
 Infectivity: This refers to the ability of a microorganism to 
invade and replicate in a host tissue, whether the microbe is 
pathogenic or not. 
 Pathogenicity: This is a qualitative trait, referring to the 
inherent, genetic capacity of a microorganism to cause 
disease, mediated by specific virulence factors. Whether or 
not it does so, is the result of the specific host-pathogen 
interactions.  
 Virulence: This is a quantitative trait, representing the extent 
of the pathology caused by a microorganism. Virulence is 
therefore a trait expressing the interaction between a 
pathogen and its host. Its definition has been re-assessed 
recently (Casadevall and Pirofski, 1999; 2001), in view of the 
significant influence of the host’s immunological condition on 
the extent of the damage (i.e. virulence) caused by a 
pathogen.  
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1.3. Virus replication and variation 
Viruses have two main characteristics that are fundamental to the 
design, analysis and interpretation of virological experiments, surveys 
and assays. These are: 
 The potential for rapid, exponential growth 
 The potential for rapid evolution and high levels of molecular   
      variability 
Below we briefly discuss these two features and their impact on 
experimentation and data management. 
 
1.3.1. The mathematics of virus replication and transmission 
Viruses are obligatory cell parasites and as such are capable of rapid, 
exponential growth. This is particularly the case for viral replication 
within individual organisms. This means that the virus replication 
dynamics can range from linear (when the virus persists as a covert 
infection, with minimal replication) all the way to fully logarithmic 
(when the virus is growing exponentially) and back to linear again 
when the maximum virus load within diseased or dying organisms is 
reached, due to exhaustion of the resources for replication (Fig. 2).    
The epidemiological spread between organisms is influenced by 
the transmission medium (air, water, vector), whose rules of 
dispersion are often not fully exponential. This also applies to other 
barriers to virus proliferation, such as tissue-specificity, interference, 
auto-interference, RNA silencing, and immune reactions which all can 
influence virus multiplication, shedding and dispersal. These 
restrictions can temper the logarithmic character of the quantitative 
virus data distribution, at the individual bee, colony or regional level. 
What this means is that, from the design of experiments through 
to the analysis of the data, allowance has to be made for non-linear 
distributions of the data, ranging from fully logarithmic (pathogenic 
replication) through semi-exponential (epidemic proliferation) to near-
linear (covert replication, dispersal). This can be addressed through 
transformations, thresholds or non-linear models, but it MUST be 
dealt with appropriately. Guidelines for this can be found in detail in 
the BEEBOOK paper on statistical methods (Pirk et al., 2013), with 
aspects specific to virus research also covered in section 3; “Statistical 
Aspects” of this chapter. 
 
1.3.2. Virus variability and evolution 
The second major characteristic of viruses, particularly important 
when designing molecular assays, is the ease and speed with which 
they can generate and maintain large amounts of molecular 
variability. The virus encoded RNA dependant RNA polymerase 
(RdRp), which facilitates genome replication, lacks proofreading and 
repair mechanisms causing a high mutation rate in RNA viruses. 
Therefore a virus is not so much an individual entity with a fixed 
genome, but rather a large ‘swarm’ of closely related variants, 
recombinants and other genetic oddities that are transmitted between  
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individuals as a unit. There are two forces that shape the genetic 
identity of such a ‘mutant swarm’ (or ‘quasi-species’ as it is officially 
known) 
 Fierce competition between molecular variants for supremacy 
in a particular cell, host etc. 
 Functional co-operation between variants, where a 
temporarily disfavoured variant can remain within the quasi-
species by ‘borrowing’ essential functions such as replication 
and packaging from the locally dominant variant.  
The functional co-operation is an adaptive super-feature of viruses, 
since it allows a wide range of genetic diversity to persist within a 
quasi-species across time, hosts and environments. The true adaptive 
strength of a virus lies therefore more in the diversity within the 
swarm than in the evolutionary abilities of any one strain. 
The importance of this variability for experimentation is in the 
design of diagnostic assays for virus detection. Serological assays, 
such as ELISA, are generally not affected by this variability which is 
mainly expressed at the nucleic acid level. However, nucleic acid 
assays, especially those based on the Polymerase Chain Reaction 
(PCR), are often very sensitive to microvariation at the nucleotide 
level, where even a single base-pair difference can be exploited for 
specific diagnosis. It is here therefore that supreme care must be 
taken to ensure that the assays developed for detecting viruses, or 
virus strains, are designed accurately and conservatively, to avoid non
-detection due to assay inadequacy (see also section 12; “Quality Control”).  
 
 
2. Virus surveys 
2.1. Introduction 
Bee diseases caused by viruses are significant threats to apiculture. 
Pathogen surveillance is an essential component of a structured 
(inter)national management strategy to contain or prevent epidemics 
of viral diseases in honey bee populations. Such surveillance is done 
both through questionnaires of beekeepers (see the BEEBOOK paper 
on surveys; van der Zee et al., 2013) and through monitoring bee 
colonies for pathogen prevalence and amount.  
Although some honey bee viruses, such as chronic bee paralysis 
virus (CBPV), deformed wing virus (DWV), black queen cell virus 
(BQCV), sacbrood bee virus (SBV) and cloudy wing virus (CWV), are 
capable of causing diseases  with recognizable symptoms, most honey 
bee viruses usually persist and spread between colonies as covert 
infections without apparent symptoms in bees. Many other bee 
viruses such as bee virus X and bee virus Y (BVX; BVY) or filamentous 
virus (AmFV), either do not cause outward symptoms at all, or others, 
such as slow bee paralysis virus (SBPV) and acute bee paralysis virus 
(ABPV) only do so under laboratory conditions or produce vague, non-
descript symptoms, such as ‘early death’ by Kashmir bee virus (KBV) 
and Israeli acute paralysis virus (IAPV) or ‘clustering’ associated with 
Apis iridescent virus (AIV). Many bee virus infections cannot therefore 
be identified through field observations, because the symptoms are 
non-existent, inconsistent or absent due to low titres. Until field-ready 
pathogen ID-kits become available, pathological analysis requires the 
transport of samples to a laboratory for analysis.  
 
2.2. Types of survey 
In epidemiology, there are two broad types of pathogen surveillance 
systems. Although they are often treated together in summaries and 
reviews, they are in fact radically different in purpose, strategy, 
methods and implications. Here we discuss these briefly as they apply 
to honey bee virus surveillance. For more detail information on how to 
manage these different approaches, see the BEEBOOK papers on 
epidemiology (vanEngelsdorp et al., 2013) and surveys (van der Zee 
et al., 2013).  
 
2.2.1. Passive surveillance 
This is the type of survey where beekeepers voluntarily send in 
suspect bee samples to a diagnostic laboratory for analysis. Most 
countries operate such a service and often the samples are of colonies 
that died suddenly, usually after winter. The survey is ‘passive’ since it 
only analyses material received from the public. It is analogous in 
human epidemiology to the entry reports of health care facilities for 
active disease cases. There is no statistically designed sampling 
strategy, samples will be biased by beekeeper interest, experience 
and knowledge and proximity to the diagnostic facilities. Samples will 
arrive in various states of decomposition making definitive diagnosis 
problematic (see section 4; ‘Virus Sample Management’), the data will 
be heavily biased towards diseased colonies with high pathogen 
prevalence/titre and the results will be more relevant to the 
management of epidemics rather than to their prevention. 
 
2.2.2. Active surveillance 
Active surveillance schemes fill many of the gaps of passive 
surveillance. These are usually statistically designed sampling 
schemes to determine pathogen prevalence within the general bee 
population, irrespective of symptoms. The bee samples are alive when 
collected, making molecular detection uniform and reliable, and the 
data are an accurate representation of the complete pathogen 
presence within a region. Often samples are taken repeatedly from 
the same colonies throughout a season, which has to be taken into 
account during data analysis. A sub-category of active surveillance 
systems is ‘sentinel’ surveillance, i.e. a series of designated 
‘monitoring’ colonies placed to catch certain pathogens before they 
reach a particular region. 
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3. Statistical aspects 
3.1. Introduction 
Whether experimenting or conducting surveys, data will be generated 
that will need to be analysed, and this requires the use of statistics. 
Fortunately, there are excellent statistical tools available right now for 
helping design experiments, determining the sample size needed to 
be able to make certain conclusions, for analysing the data and for 
modelling and prediction. It is highly recommended to include an 
expert statistician in the project right from the beginning, at the 
design stage. It will mean that the experiment is set up correctly, that 
sampling is as efficient as possible and that the data are analysed 
correctly. The most important statistical concepts and practices 
relevant to honey bee research and surveying are covered in the 
BEEBOOK paper on statistical methods (Pirk et al., 2013), to which 
the reader is referred to for guidance. 
 
3.2. Statistical distribution of virus data 
The major additional point specifically relevant to honey bee virus 
research (and probably other pathogens) is that virus titres follow an 
Exponential (~Logarithmic) distribution, rather than a Normal 
distribution (Fig. 2; Gauthier et al., 2007; Brunetto et al., 2009; Yañez 
et al., 2012; Locke et al., 2012). Also, the prevalence of very rare 
viruses (pathogens, parasites) may follow a Poisson distribution rather 
than a Binomial distribution. These differences in how the primary 
virus data is statistically distributed affects the design of an 
experiment, the determination of sample sizes (Wolfe and Carlin, 
1999), surveying strategy, the analysis of pooled samples and the 
management of the data produced. This subject is treated in more 
detail in the BEEBOOK paper on statistical methods (Pirk et al., 2013).  
 
3.2.1. Log-transformation 
Exponentially distributed data (i.e. quantitative virus titre data) must 
be treated with a power transformation (Box and Cox, 1964; Bickle 
and Doksum, 1981), usually a log-transformation, before they can be 
used to estimate descriptive statistics (means, medians, variances 
etc.) or be used in parametric statistical analyses (ANOVAs, 
correlations, GLMs etc.). This can be done prior to statistical analysis, 
or can be incorporated as part of the statistical analysis.  
 
3.2.2. Zero values 
Since it is not possible to log-transform zero values, instances of non-
detection (i.e. a ‘zero’ value) should be replaced by a non-zero 
constant value appropriate to the variable in question (Cox et al., 
2000). A logical constant value to use for replacing zero-values in 
quantitative virus data sets is one that is set just below the detection 
threshold for the virus in question (Yañez et al., 2012; Locke et al., 
2012). This approach treats zero values as “below detection 
threshold” rather than as “absence of virus”, which is usually also a 
more accurate description of the virus status of a sample, especially if 
the virus is known to be present within the wider bee population. 
 
 
4. Virus sample management 
4.1. Introduction 
The aim of a survey or experiment is that the final data should as 
closely as possible represent the (virus) status of the bee or colony 
when the sample was taken, since ultimately the data interpretation, 
conclusions and recommendations will again refer to live bees. 
Sample  management (from collection and field preservation, to 
transportation, short- and long-term storage, processing and finally 
analysis) is therefore crucial to the accurate interpretation of survey 
and experimental data. Honey bee sample management is covered in 
detail in the BEEBOOK paper on molecular methods (Evans et al., 
2013) with a reduced version given below. Most viruses have an RNA 
genome and much of the host’s molecular response to virus infection 
is also at the RNA level. However, RNA is highly sensitive to 
degradation by nucleases and a major criterion for bee sample 
management is therefore to minimize this degradation (Chen et al., 
2007; Dainat et al., 2011). The primary concern is not so much the 
virus particle (which is usually relatively robust), but rather the viral 
replicative RNA intermediates and host mRNAs.    
 
4.2. What, where and when to sample 
Different viruses have different infection patterns, life-stage/tissue 
preferences and seasonal prevalences (Table 2), and so the decision 
as to what bee stages to sample, when/how often to sample and 
where to sample depends to a large degree on the objective of the 
experiment/survey and on the virus studied. When the experiments/
surveys are detailed and specific, the sampling regimen should be 
designed to suit those specific aims. However, often the same 
samples will be analysed for multiple viruses, or the experiments/
surveys are more global in character, requiring a more consensual 
approach to sampling. Here are some considerations for making 
sampling decisions in these situations. See also the BEEBOOK paper 
on statistical methods (Pirk et al., 2013) for decisions on how to 
determine the optimal sample size and pooled samples.  
 
4.2.1. What to sample? 
All viruses described to date can be detected in adult bees (Table 2). 
This is logical, since adult bees are central to most of the virus 
transmission pathways (Fig. 1), due to their high mobility, contact 
rate and diverse contact network. This makes adult bees the most 
suitable single bee stage for detecting all viruses. Within adult bees, 
the gut is a major site of accumulation for most viruses (and many 
other pathogens), and is thus the most suitable single tissue type for 
sampling.    
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4.2.2. Where to sample? 
The difficulty with adult bees is that the virus titre can be influenced 
by the age and the tasks of the bee. It is therefore advisable to 
sample as much as possible the same age/task group throughout the 
experiment, in order to minimize the influence of such effects on the 
data (Van der Steen et al., 2012). In practical terms, this means 
either sampling from the brood chamber (mostly young nurse bees), 
the honey supers (medium-age bees) or at the entrance (older 
foraging bees). The choice of age-class for sampling is less important 
than consistently sampling the same age-class. See also the BEEBOOK 
paper on statistical methods (Pirk et al., 2013).  
 
4.2.3. When to sample? 
There are two considerations here. The first is the best time of day to 
collect a sample and the second how often to sample. The best time 
to sample is either on sunny days, during the afternoon, when bees 
are actively foraging and the adult population is most clearly 
subdivided according to tasks/age, or at the other extreme during 
cold rainy days, when there is no substructuring of the population and 
all bees are sampled randomly, irrespective of age class. This choice 
depends on the design and purpose of the sampling scheme. 
The frequency of sampling depends on the type survey/
experiment conducted:  
 For single virus geographic prevalence surveys, the best time 
of year for sample collection would be during the seasonal 
peak for the virus in question (Table 2).  
 For multivirus-pathogen geographic prevalence surveys, and if 
only a single sample is collected, the best time would be 
autumn, when most viruses have a seasonal peak.  
 For multivirus-pathogen surveys it is advisable to sample at 
least three times per season; in early spring when the colony 
is expanding, during peak productivity in summer and during 
late autumn when the colony is contracting, in order to catch 
the different pathogens at their peaks, observe seasonal 
variations in prevalence and identify possible associations 
between different pathogens-parasites. 
 For colony-level experiments with repetitive sampling, it may 
be useful to take into account the natural turnover of the 
adult population when considering sampling frequency. During 
summer, both the brood stage and the adult stage last about 
three weeks. Sampling every three weeks therefore means 
that a completely new generation of adult bees is sampled 
each time, corresponding to the brood generation of the 
previous sampling point.  
 
4.3. Sample collection 
Methods for collecting different sample types (adults vs brood; whole 
bees vs extracted tissues), for sample preservation (chemical and/or 
temperature) and for transportation (hours vs days) are described in 
detail in the BEEBOOK paper on molecular methods (Evans et al., 
2013). Faeces may be a useful sample type for the non-destructive or 
repetitive sampling of the individual bees, such as queens (Hung, 
2000). The general rules for sample collection are to get the samples 
to a freezer as quick as possible, and to keep dead, preserved or 
processed bee samples as cold as possible during transport.    
 
4.3.1. Adult bees 
Adult bees are usually collected from brood frames (young bees); 
honey frames (older bees); at the hive entrance (foragers) or in dead-
bee traps (dead bees). Around 200 bees (about 20g, or a cup-full) are 
shaken or brushed into either a cage or ventilated box with food (live 
transport) or in a 1l plastic bag (cold transport). This is enough for 
both mite and virus analyses.   
 
4.3.2. Pupae 
Pupae are usually collected as a 10cm x 10cm section of sealed 
brood, placed in a suitably sized ventilated box (live transport) or in a 
plastic bag (cold transport). Individual pupae can be collected in 
microcentrifuge tubes or on collection cards (see section 4.4.5.).  
 
4.3.3. Larvae 
Larvae are usually collected in tubes or on collection cards and 
transported on ice, since they tend to crawl out of comb sections 
during live transport.  
 
4.3.4. Eggs 
Eggs can be collected as cut comb section, transported in a non-
ventilated container to prevent dehydration, or individually in tubes or 
on collection cards.  
 
4.3.5. Extracted guts 
Adult bee guts can be collected by carefully pulling out the stinger 
plus last integument, and slowly drawing out the hind and midgut. 
Extracted guts can be transported in tubes or on collection cards, on ice.  
 
4.3.6. Drone endophallus and semen 
Drone endophali and/or semen can be collected by squeezing out the 
endophallus as described in the BEEBOOK article on artificial 
insemination (Cobey et al., 2013). The endophallus or semen can be 
transported in tubes or on collection cards, on ice.  
 
4.3.7. Faeces 
Faeces can be collected destructively by removing the bee gut (see 
section 4.3.5.) and expelling the faeces, or non-destructively by 
placing the bee in a petri dish and waiting for defecation.  
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4.3.8. Dead colonies  
Many virus experiments involve bee death as a parameter. Dead bee 
samples from such experiments should be treated like freshly killed 
material and frozen as soon as possible to minimize the effects of 
decay on RNA integrity.  
Passive surveys also involve dead bee samples, in this case those 
sent in by beekeepers for post-mortem analysis of the cause of colony 
death. The RNA from such bees will most likely be degraded, which 
will affect the reliability of the data, especially of negative results 
(virus absence). How to manage such samples and data is covered in 
detail in the BEEBOOK paper on molecular methods (Evans et al., 
2013). Collect the more desiccated dead bees and transport in a 
ventilated cardboard box at ambient temperature.  
 
4.4. Sample transport  
The integrity of samples can stabilized during transport by:  
 
4.4.1. Freezing 
Freezing on-site is the gold standard for sample transport, but usually 
too expensive for mass surveys. There are several alternatives for 
different purposes and samples sizes (see the BEEBOOK paper on 
molecular techniques; Evans et al., 2013), including the ‘dry shipper’ 
which can hold up to 1300 2-ml cryo-tubes below freezing for up to 3 
weeks and is approved for international air-shipment.  
 
4.4.2. Ice 
Transport on ice is a cheap and practical substitute for freezing, if the 
samples can be (re)-frozen within 48 hours.  
 
4.4.3. Live transport 
Live transport is very practical and cheap, especially if the samples are 
sent by post. Obviously there is no RNA degradation due to bee 
death, but live transport may affect the expression of host genes, and 
possibly virus replication, which should be taken into account when 
planning experiments.    
 
4.4.4. Chemical stabilizers 
There are a number of chemicals that help prevent RNA degradation. 
For these to work, they have to penetrate the bee exoskeleton and 
get into the tissues. They are therefore more useful for extracted 
tissues, eggs and larvae and less useful for adult bees. There are two 
types of chemical preservation: salts (in solution or impregnated on 
collection cards) and organic solvents (usually alcohol). Solvents 
penetrate the exoskeleton better than salt solutions and are more 
suitable for adult bees. A large excess (>5-fold by weight) should be 
used to make sure the chemical’s concentration in the tissues is high 
enough to inhibit the nucleases. Various solutions and how to use 
them are described in the BEEBOOK paper on molecular methods 
(Evans et al., 2013).  
4.4.5. Sample collection cards 
FTA™ collection cards (Whatman) preserve tissues both by 
desiccation and chemical (salt) preservatives embedded in the filter 
paper (Becker et al., 2004; Rensen et al., 2005). They are ideal for 
soft tissues and for remote collecting situations where sample weight 
and ambient storage are important factors. They are very reliable, but 
pricey, only suitable for small sample sizes and processing can be messy. 
See the BEEBOOK paper on molecular methods (Evans et al., 2013).   
 
4.5. Long-term sample storage 
The factors important for long-term storage and preservation are the 
same ones highlighted for sample transport, which are (in order of 
effectiveness): temperature, desiccation (lyophilisation) and chemical 
preservatives. See the BEEBOOK paper on molecular methods (Evans 
et al., 2013) for details.  
 
 
5. Virus propagation 
5.1. Introduction 
The methods for propagating and purifying honey bee viruses in bees 
have not changed much from those described by Bailey and Ball 
(1991). Many viruses, including all of the important ‘picorna-like’ 
viruses, can be propagated by injection in either pupae or adult bees. 
Pupal injections are easier to manage than injection into adult bees, 
from pretty much every aspect: injection, incubation, homogenization 
and purification. Some viruses can only be infected orally and/or are 
only infectious in adult bees. The propagation criteria for each virus 
are listed in Table 3. Infectivity tests are essentially more precise versions 
of the propagation protocols. Another way to propagate and purify 
honey bee viruses is through tissue culture. This removes the potential 
for contamination and the dependence on the bee season that comes 
with propagating in bees, and allows for large volume propagation. It 
also is a highly effective tool for detailed laboratory experimentation 
at cellular level, without the influence of bee and hive effects. Attempts 
at virus propagation in bee tissue culture have so far met with limited 
success. However, significant progress has recently been made with 
Nosema cultivation in commercial (Lepidopteran) insect cell lines (see 
the BEEBOOK paper on cell culture (Genersch et al., 2013).   
 
5.2. Starting material 
Often the starting material for propagation is a previous virus 
preparation that has been checked for the absence of contaminating 
viruses and retained as a pure isolate. Virus preparations can, 
however, lose infectivity during prolonged storage. For example 
deformed wing virus (DWV) and its relatives kakugo virus (KV) and 
Varroa destructor virus-1 (VDV-1), are particularly sensitive to decay 
during storage. Since neither serological nor molecular assays can 
distinguish between degraded or intact virus particles, they are not 
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reliable methods for determining the infectivity of a preparation. 
Furthermore, such well-characterized and precious reference material 
is often in limited supply and highly valuable as a historical 
“reference” isolate for future experiments. Such reference material 
can be stored long-term either as freeze-dried bees/pupae/larvae, or 
as a (semi)purified virus solution in an appropriate virus purification 
buffer (Table 4) and stabilized by 50% glycerol. It is therefore 
advisable, particularly for infectivity tests but also for propagation, to 
first prepare a “working” inoculum, by injecting or feeding a small 
number of bees (larvae, pupae or adults; around 5-10 individuals) 
with a small amount of the pure reference material. This also serves 
as an infectivity test for the viability of the stored reference material. 
After incubating for the appropriate time, a crude extract should be 
prepared from the bees, the purity and virus concentration of this 
extract determined, and then this working extract should be used for 
large-scale propagation or infectivity tests within the next few of 
weeks. 
 
5.3. Oral propagation 
Oral propagation is relatively inefficient for most viruses, requiring 
high titre inoculums (106-1011 particles, depending on the virus; Table 
3) to establish an infection (Bailey and Gibbs, 1964; Bailey and Ball, 
1991).   
 
5.3.1. Larvae 
1.   Mix purified virus of the appropriate minimum concentration 
(Table 3) with medium for in-vitro larval rearing and allocate 
this to the wells of a 48-well tissue culture plate (see the 
BEEBOOK paper on in-vitro larval rearing (Crailsheim et al., 
2013). 
2.   Transfer two-day old larvae to the wells, making sure there is 
enough virus so that each larva gets the minimum infectious 
dose. 
3.   Follow the procedures for in-vitro larval rearing (see the 
BEEBOOK paper on in-vitro larval rearing (Crailsheim et al., 
2013), transferring the larvae periodically to fresh food, either 
including or excluding further virus extract. 
4.   Include a series of control inoculations, using larval food 
medium without virus.   
 
 
 
 
5.3.2. Adults 
1.   Mix purified virus with 60% sucrose to the desired 
concentration for infecting bees individually or in bulk.  
2.   Feed the virus-sucrose solution individually to newly emerged 
adult bees in 5-10 µl volumes, using a Pasteur or micro-
pipette. 
3.   Immobilize the bees by either holding their wings or in a 
suitable restrainer, such as head-first in a 1.5 ml 
microcentrifuge tube with the bottom cut off (see the section 
The Hamilton Company produces both dispenser units and 10~50 µl 
syringes with Luer locks that fit disposable needles. The pupae can be 
injected by hand, which is faster (but less precise) than doing so 
under microscope, with moveable trays. 
7.   Attach the syringe and control unit horizontally to a stand. 
8.   Close the four fingers of your hand and carefully lay a white-
eye pupa on its back in the groove between index and middle 
finger.  
The abdomen of the pupa points towards the tip of the fingers and 
the head is supported by the tip of the thumb. 
9.   Move the pupa towards the needle, inserting the needle at the 
narrowest angle possible under the skin of the pupa, on the 
lateral side, between the 2nd and 3rd integuments of the 
abdomen.  
10. Inject 1~5 µl of virus suspension using the control unit.  
11. Move the pupa backwards off the needle.  
12. Move the pupa carefully from the hand to a plastic, disposable 
tissue culture plate, using forceps to support the pupa 
underneath.  
Use plates with matching lids, both to prevent cross-contamination 
between wells and to control the humidity. 
13.  Incubate the plate at 30°C in a humidity-controlled incubator.  
If this is not available, place the plates in a closed plastic box 
containing moistened paper towels.  
14. Check the progress of the infection by monitoring the change 
in eye colour of the pupae.  
Those pupae injected with virus that remain alive will change eye 
colour, but more slowly than those pupae injected with only buffer.  
15. Include a control series with buffer-only inoculations, and a 
control series without inoculation, just incubation of the 
pupae.     
 
The best propagations are with those inoculum concentrations 
that keep the pupae alive for as long as possible, generating the 
highest propagation concentrations. Sometimes parts of the body 
become necrotic, either only the abdomen or only the thorax/head. 
This can happen when the virus concentration of the inoculum is too 
high, killing the tissue too quickly for efficient propagation. Too low a 
virus inoculums concentration will, however, increase the risk of 
amplifying unrelated covert infections already present in the pupa.  
It is therefore advisable to first propagate a range of log-scale 
dilutions (1/10, 1/100, 1/1000 etc.) of the virus inoculum. Then for 
large-scale propagation, choose the highest inoculum concentration 
that does not necrotize the pupae before the 4th day of incubation.  
 
 
'standard methods for immobilising, terminating, and storing 
adult Apis mellifera'  in the BEEBOOK paper on miscellaneous 
methods; Human et al., 2013).  
4.   Bulk-feeding of the virus-sucrose solution to adult bees is 
done either in hoarding cages, using disposable 15 ml plastic 
feeding tubes (see the BEEBOOK paper on maintaining adult 
Apis mellifera workers in cages;  Williams et al., 2013) or in 
whole colonies using internal or top feeders. In both cases it 
is important to calculate the amount of purified virus needed 
to ensure that each bee gets the minimum infectious dose 
(Table 3). 
5.   Include a series of control inoculations, using sucrose solution 
without virus. 
 
5.4. Injection propagation 
Propagation by injection into pupae or adults is generally very 
efficient, requiring very low virus doses and concentrations to 
establish an infection (102-104 particles, depending on the virus). 
However, this high efficiency also makes propagation by injection 
susceptible to the amplification of any contaminating viruses, either 
those present in the injected inoculum or those present naturally 
within the bees. Extra care has to be taken therefore to confirm the 
purity of the propagation, after purification.  
 
5.4.1. Pupae 
1.   Lay the frame horizontally at a slight angle, bottom-to-top, 
under good light. 
2.   Using needle-forceps, remove the wax capping from 10-50 
cells containing white-eyed pupae, by cutting along the inside 
of the cell. 
It is easiest to work from the bottom of the frame upwards, clearing 
room underneath for opening up the cells higher up the frame and 
picking up the pupae from behind. 
3.   With blunt, curved forceps remove the top part of each cell, 
exposing the head of the pupa. 
4.   Place the curved forceps underneath the head of the pupa, 
from the back, and carefully lift the pupa out of its cell.  
It is critical to remove the white-eye pupae very carefully from the 
comb, to avoid damage. 
5.   Collect the pupae in a plastic Petri dish containing a circular 
filter paper dampened with sterile water. 
6.   For the purpose of propagation, you need: 
 a 10~50 µl syringe, 
 a thin needle (around 28G~30G)  
 a semi-automatic volume dispenser control unit that can 
dispense 1~5 µl volumes.  
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PROPAGATION 
VIRUS METHOD STAGE AGE 
DOSE 
INCUBATION* NOTES 
(2ng ≈ 107 particles) 
  
ORAL 
larvae  48 hour ? ?   
Acute bee  adult  < 24 hour > 1010 particles/bee ?   
(ABPV) 
INJECTION 
pupae white eye > 102 particles/bee 5 days   
  adult any > 102 particles/bee 5 days   
  
ORAL 
larvae  48 hour ? ?   
Kashmir bee virus adult  < 24 hour > 107 particles/bee 5 days   
(KBV) 
INJECTION 
pupae white eye > 102 particles/bee 3 days   
  adult any > 102 particles/bee 3 days   
  
ORAL 
larvae  48 hour ? ?   
Israeli acute  adult  < 24 hour > 4ng pure virus/bee 6 days   
(IAPV) 
INJECTION 
pupae white eye > 102 particles/bee 3 days   
  adult any > 102 particles/bee 4 days   
  
ORAL 
larvae  48 hour ? ? requires 
Black queen cell 
virus 
adult  < 24 hour > 4mg crude extract/bee 40 days 
N. apis  
co-infection 
(BQCV) 
INJECTION 
pupae white eye > 103 particles/bee 5 days   
  adult any       
Deformed wing 
ORAL 
larvae  48 hour > 109 genomes/bee 5 days   
Varroa destructor 
virus-1 
adult  < 24 hour > 108 genomes/bee ?   
(DWV & VDV-1) 
INJECTION 
pupae white eye > 102 genomes/bee 14 days   
  adult any > 107 genomes/bee 3 days   
  
ORAL 
larvae  48 hour ? ?   
Egypt bee virus adult  < 24 hour ? ?   
(EBV) 
INJECTION 
pupae white eye > 102 particles/bee 8 days   
  adult any ? ?   
  
ORAL 
larvae  48 hour   7 days   
Sacbrood virus adult  < 24 hour       
(SBV) 
INJECTION 
pupae white eye > 103 particles/bee 5 days   
  adult any       
Thai/Chinese 
ORAL 
larvae  48 hour   7 days   
Sacbrood virus adult  < 24 hour       
(TSBV) 
INJECTION 
pupae white eye > 103 particles/bee 5 days   
  adult any       
Table 3.  Summary of the protocols and conditions for the oral and injection propagation of the different honey bee viruses in larvae, pupae 
and adult bees. Non-viable propagation routes are marked with an ‘x’. Absence of reliable information is marked with ‘?’. Adapted from Bailey 
and Ball (1991).  
  
ORAL 
larvae  48 hour ? ?   
Slow bee paralysis 
virus 
adult  < 24 hour ? ?   
(SBPV) 
INJECTION 
pupae white eye > 103 particles/bee 5 days   
  adult any > 103 particles/bee 12 days   
  
ORAL 
larvae  48 hour > 1010 particles/bee 5 days   
  adult  < 24 hour > 1010 particles/bee ? days   
Chronic bee  
paralysis virus CONTACT 
larvae x x x   
(CBPV) adult  < 48 hour > 107 genomes/bee     
  
INJECTION 
pupae white eye > 102 particles/bee 5 days   
  adult any > 102 particles/bee 7 days   
  
5.4.2. Adults 
Propagation in adult bees is best done with newly emerged bees, 
whose exoskeleton is still soft, making it easier for controlled 
injection. Using young bees also avoids any age-related variability in 
propagation and unintentional propagation of adult-acquired viruses. 
1.  Collect the bees in lots of 10-20 in queen cages, or similar 
containers. 
2. Anaesthetize the bees for 1 minute with CO2 from a 
pressurized cylinder. 
3. Make sure to bubble the CO2 gas through water to melt any 
CO2 micro-particles, which can be very injurious to bees. See  
the section 'Standard methods for immobilising, terminating, 
and storing adult Apis mellifera' in the BEEBOOK paper on 
miscellaneous methods (Human et al., 2013). 
4. Proceed quickly to avoid excess anaesthesia for the bees and 
do not anaesthetize the bees more than once a day.  
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Bees sometimes die from excess anaesthesia. This is 
especially important for infectivity tests, where the death of a 
bee is often a recorded experimental variable.  
5.   Inject 1~5 µl of virus suspension between the 2nd and 3rd 
integuments of the bee using a similar controlled-volume 
syringe set-up as for pupal propagation (see section 5.4.1.). 
6.   Incubate the inoculated bees in a hoarding cage at 30°C in 60
-70% relative humidity with sufficient sterilized food and 
water (see the BEEBOOK paper on maintaining adult  
Apis mellifera workers in cages (Williams et al., 2013) for the 
appropriate amount of time for each virus (Table 3).    
7.   Include a control series with buffer-only inoculations, and a 
control series without inoculation, just incubation of the adult 
bees. 
 
 
 
Table 3. continued  
VIRUS METHOD STAGE AGE 
DOSE 
INCUBATION* NOTES 
(2ng ≈ 107 particles) 
  
CONTACT 
larvae ? ? ?   
Cloudy wing virus adult ? ? ?   
(CWV) 
INJECTION 
pupae x x x   
  adult x x x   
  
ORAL 
larvae x x x enhanced by  
Bee virus X adult  < 24 hour > 4mg crude extract/bee 30 days 
M. mellificae 
co-infection 
(BVX) 
INJECTION 
pupae x x x   
  adult x x x   
  
ORAL 
larvae x x x requires 
Bee virus Y adult  < 24 hour > 4mg crude extract/bee 30 days 
N. apis  
co-infection 
(BVY) 
INJECTION 
pupae x x x   
  adult x x x   
  
ORAL 
larvae  48 hour ? ?   
Arkansas bee virus adult  < 24 hour ? ?   
(ABV) 
INJECTION 
pupae white eye > 103 particles/bee 5 days   
  adult any > 103 particles/bee 21 days   
  
ORAL 
larvae ? ? ? enhanced by  
Filamentous virus adult  < 24 hour > 4mg crude extract/bee 30 days N. apis  
(AmFV) 
INJECTION 
pupae x x x   
  adult x x x   
  
ORAL 
larvae  48 hour ? ?   
Apis iridescent virus adult  < 24 hour ? ?   
(AIV) 
INJECTION 
pupae white eye > 103 particles/bee 5 days   
  adult any       
         * based on minimum  
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Table 4. Summary of the protocols for the purification of the different honey bee viruses.  Adapted from Bailey and Ball (1991).  
PURIFICATION 
VIRUS 
EXTRACTION  
BUFFER (2 ml/g tissue) 
LOW-SPEED  
CENTRIFUGE 
HIGH-SPEED  
CENTRIFUGE 
RESUSPENSION  
BUFFER (0.1 ml/g tissue) 
SUCROSE  
GRADIENTS 
Acute bee paralysis virus 
(ABPV) 
0.01M potassium phosphate (7.0) 8000 g 75 000 g 0.01M potassium phosphate (7.0) 45 000 g 
0.02% diethyldithiocarbamate 10 minutes 3 hours incubate 12-36 hours; 5°C 3 hours 
0.1 volume ether 15°C 15°C low-speed centrifugation; 5°C 4°C 
0.1 volume carbon tetrachloride supernatant retain pellet  collect band 
Kashmir bee virus  
(KBV & IAPV) 
0.01M potassium phosphate (7.0) 8000 g 75 000 g 0.01M potassium phosphate (7.0) 45 000 g 
0.02% diethyldithiocarbamate 10 minutes 3 hours incubate 12-36 hours; 5°C 3 hours 
0.1 volume ether 15°C 15°C low-speed centrifugation; 5°C 4°C 
0.1 volume carbon tetrachloride supernatant retain pellet   collect band 
Israeli acute  
paralysis virus  
(IAPV) 
0.01M potassium phosphate (7.6) 10 000 g 100 000 g 0.01M potassium phosphate (7.6) 100 000 g* 
0.2% Na-deoxycholate 20 minutes 3 hours 0.6 g/ml CsCl 24 hours* 
2% BRIJ-58 15°C 15°C * CsCl gradient centrifugation 20°C 
 supernatant retain pellet   collect band 
Black queen cell virus 
(BQCV) 
0.01M potassium phosphate (7.0) 8000 g 75 000 g 0.01M potassium phosphate (7.0) 45 000 g 
0.02% diethyldithiocarbamate 10 minutes 3 hours incubate 12-36 hours; 5°C 3 hours 
0.1 volume ether 15°C 15°C low-speed centrifugation; 5°C 4°C 
0.1 volume CCl4 supernatant retain pellet  collect band 
Deformed wing virus & 
Varroa destructor virus-1 
(DWV & VDV-1) 
0.5M potassium phosphate (8.0) 8000 g 75 000 g 0.5M potassium phosphate (8.0) 45 000 g 
0.2% diethyldithiocarbamate 10 minutes 3 hours immediately to sucrose gradients 3 hours 
0.1 volume ether 15°C 15°C   4°C 
0.1 volume carbon tetrachloride supernatant retain pellet   collect band 
Egypt bee virus  
(EBV) 
0.5M potassium phosphate (8.0) 8000 g 75 000 g 0.5M potassium phosphate (8.0) 45 000 g 
2% ethylene diamine tetra acetic acid 10 minutes 3 hours immediately to sucrose gradients 3 hours 
1% ascorbic acid; 0.1 volume ether 15°C 15°C   4°C 
0.1 volume carbon tetrachloride supernatant retain pellet   collect band 
Sacbrood virus  
(SBV) 
0.01M potassium phosphate (7.0) 8000 g 75 000 g 0.01M potassium phosphate (7.0) 45 000 g 
0.02% diethyldithiocarbamate 10 minutes 3 hours incubate 12-36 hours; 5°C 3 hours 
0.1 volume ether 15°C 15°C low-speed centrifugation; 5°C 4°C 
0.1 volume carbon tetrachloride supernatant retain pellet   collect band 
Thai/Chinese  
Sacbrood virus  
(TSBV) 
0.5M potassium phosphate (8.0) 8000 g 75 000 g 0.5M potassium phosphate (8.0) 45 000 g 
0.2% diethyldithiocarbamate 10 minutes 3 hours 0.02M ethylene diamine tetra acetic acid 3 hours 
0.02M ethylene diamine tetra acetic acid 15°C 15°C   4°C 
0.1 volumes ether; carbon tetrachloride supernatant retain pellet  collect band 
Slow bee paralysis virus 
(SBPV) 
0.01M potassium phosphate (7.0) 8000 g 75 000 g 0.01M potassium phosphate (7.0) 45 000 g 
0.02% diethyldithiocarbamate 10 minutes 3 hours incubate 12-36 hours; 5°C 3 hours 
0.1 volume ether 15°C 15°C low-speed centrifugation; 5°C 4°C 
0.1 volume carbon tetrachloride supernatant retain pellet   collect band 
Chronic bee  
paralysis virus  
(CBPV) 
0.2M potassium phosphate (7.5) 3000 g 100 000 g 0.2M potassium phosphate (7.5) 45 000 g 
0.02% diethyldithiocarbamate 30 minutes 2 hours 15°C 4.5 hours 
0.1 volume ether 15°C 15°C   15°C 
0.1 volume carbon tetrachloride supernatant retain pellet   collect band 
  
5.5. Tissue culture 
The importance of a viable tissue-culture system for the purification 
and propagation of honey bee viruses has long been acknowledged. 
There are two possible approaches to such a system. One is to 
develop a reliable, immortal honey bee cell line for infection. Only 
recently has there been any significant progress towards this goal 
(Bergem et al., 2006; Hunter, 2010; Kitagishi et al., 2011; Gisder et al., 
2012). The other approach is to propagate honey bee viruses in 
existing commercial, heterologous insect cell lines. Many of the honey 
bee viruses naturally infect other insect hosts, such as other Apis spp., 
varroa and tropilaelaps parasitic mites, bumble bees, wasps, ants and 
a range of solitary pollinators  (Bailey and Gibbs, 1964; de Miranda  
et al., 2010a; de Miranda and Genersch, 2010; Ribière et al., 2010; 
Dainat et al., 2009; Singh et al., 2010; Peng et al., 2011; Li et al., 
2011; DiPrisco et al., 2011; Zhang et al., 2012; Evison et al., 2012) 
and the replication-translation control regions of honey bee virus 
genomes are active in several commercial Lepidopteran and Dipteran  
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cell lines (Ongus et al., 2006). Protocols for the establishment and 
maintenance of honey bee and commercial insect cell lines can be 
found in the BEEBOOK article on cell cultures (Genersch et al., 2013). 
 
5.5.1. Virus infection 
The most common method of infecting tissue culture cells is through 
passive co-incubation of purified virus particles with the cells, allowing 
the natural processes of virus entry to establish an infection (Minor, 
1985; Gantzer et al., 1998; Rhodes et al., 2011; Amdiouni et al., 
2012). However, the virus particles (or the naked viral RNA genome) 
can also be forced into the cells using electroporation, which involves 
a short high-voltage pulse of electricity to temporarily open up the cell 
membrane to allow foreign elements to enter the cell, or chemical-
mediated transfection, where a combination of membrane-active ions 
and concentrating agents interact to encourage the uptake of the 
virus or nucleic acid into the cell (e.g. Boyer and Haenni, 1994; 
Table 4. Cont’d. 
PURIFICATION 
VIRUS 
EXTRACTION  
BUFFER (2 ml/g tissue) 
LOW-SPEED  
CENTRIFUGE 
HIGH-SPEED  
CENTRIFUGE 
RESUSPENSION  
BUFFER (0.1 ml/g tissue) 
SUCROSE  
GRADIENTS 
Cloudy wing virus  
(CWV) 
0.5M potassium phosphate (8.0) 8000 g 75 000 g 0.5M potassium phosphate (8.0) 45 000 g 
0.2% diethyldithiocarbamate 10 minutes 3.5 hours immediately to sucrose gradients 4.5 hours 
0.1 volume ether 15°C 15°C   4°C 
0.1 volume carbon tetrachloride supernatant retain pellet   collect band 
Bee virus X  
(BVX) 
0.01M potassium phosphate (7.0) 8000 g 75 000 g 0.01M potassium phosphate (7.0) 45 000 g 
0.02% diethyldithiocarbamate 10 minutes 3 hours equal volume 0.2M ammonium acetate (5.0) 3 hours 
0.1 volume ether 15°C 15°C low-speed & high-speed centrifugation 4°C 
0.1 volume carbon tetrachloride supernatant retain pellet resuspend 0.1M ammonium acetate (7.0) collect band 
 Bee virus Y  
(BVY) 
0.01M potassium phosphate (7.0) 8000 g 75 000 g 0.01M potassium phosphate (7.0) 45 000 g 
0.02% diethyldithiocarbamate 10 minutes 3 hours equal volume 0.2M ammonium acetate (5.0) 3 hours 
0.1 volume ether 15°C 15°C low-speed & high-speed centrifugation 4°C 
0.1 volume carbon tetrachloride supernatant retain pellet resuspend 0.1M ammonium acetate (7.0) collect band 
Arkansas bee virus 
(ArkBV) 
0.01M potassium phosphate (7.0) 8000 g 75 000 g 0.01M potassium phosphate (7.0) 45 000 g 
0.02% diethyldithiocarbamate 10 minutes 3 hours incubate 12-36 hours; 5°C 3 hours 
0.1 volume ether 15°C 15°C low-speed centrifugation; 5°C 4°C 
0.1 volume carbon tetrachloride supernatant retain pellet   collect band 
  Filamentous virus 
(AmFV)   
0.01M ammonium acetate (7.0) 150 g 30 000 g 0.1M ammonium acetate (7.0) 10 000 g 
0.02% diethyldithiocarbamate 10 minutes 30 minutes layer on 50% w/v sucrose 30 minutes 
  15°C 15°C centrifuge 75 000g, 3 hours, 15°C 5°C 
  supernatant retain pellet resuspend 0.1M ammonium acetate (7.0) collect band 
  Apis iridescent virus 
(AIV)   
0.01M potassium phosphate (7.0) 150 g 30 000 g 0.01M potassium phosphate (7.0) 10 000 g 
0.02% diethyldithiocarbamate 10 minutes 30 minutes incubate 12-36 hours; 5°C 30 minutes 
0.1 volume carbon tetrachloride 15°C 15°C low-speed centrifugation; 5°C 5°C 
  supernatant retain pellet  collect band 
Benjeddou et al., 2002; Ongus et al., 2006; Yunus et al., 2010). 
Whichever virus transfection protocol is chosen, it is essential that the 
virus preparation is free of bacteria or fungi to prevent contamination 
of the tissue culture (Minor, 1985; Gantzer et al., 1998). Bacteria, 
fungi and their spores can be effectively removed from a virus 
preparation using microfilters with appropriate pore size, depending 
on the size of the virus (Gantzer et al., 1998; Rhodes et al., 2011; 
Amdiouni et al., 2012), with 0.2 µm suitable for purifying most small, 
enteric picorna-like viruses of around 30-60nm (Rhodes et al., 2011; 
Amdiouni et al., 2012), which includes most of the honey bee RNA 
viruses (Table 2). 
 
5.6. Full-length infectious virus clones 
A supremely powerful tool in RNA virus research is cloning full-length 
genomic sequences of the virus into bacterial vectors. The naked RNA 
transcribed from such clones is usually infectious when introduced into 
a suitable host (Yunus et al., 2010), especially for positive-stranded RNA 
viruses (i.e. the majority of known bee viruses). Such clones can be 
manipulated by site-directed mutagenesis and recombination for 
functional analysis of different open reading frames or control regions. 
Reporter genes such as green fluorescent protein can be inserted to 
make fusion proteins with viral genes or to study promoter function in 
real-time (Ongus et al., 2006) and of course they can function as a 
genetically pure source of infectious virus, rather than having to rely 
on biological propagation with the associated dangers of contamination 
with other viruses and the changing genetic constitution of the virus, 
through evolution.  
Full-length viral cDNAs are also an important tool in studying the 
genetic complexity of virus populations, since they make it possible to 
identify complete sequences of individual viruses within the population, 
including natural recombinants between major variants (Palacios et al., 
2007; Moore et al., 2011).  
 
5.6.1. Full-length viral RNA synthesis strategies 
Full-length cloning of viral genomes has been a common tool in virology 
since the 1980’s (Taniguchi et al., 1978; Lowry et al., 1980; Racaniello 
and Baltimore, 1981), but it is often a long and tedious process, mostly 
due to the frequent instability of the full-length clones in bacteria 
(Boyer and Haenni, 1994). It is thought that cryptic bacterial promoters 
and secondary structures within the viral sequences encourage the 
bacteria to excise problematic viral regions from the plasmid clone. 
Full-length clones therefore have to be monitored constantly for 
possible deletions and re-arrangements as part of their maintenance. 
The process has been made easier by improvements in cloning 
techniques and the stability of the cloning vectors with respect to 
accepting and maintaining long (~10kb) inserts. There are several 
alternatives to cloning full-length genomes. Sometimes it is easier to 
clone the genome in several partial clones first, and then recombine 
these afterwards into a single full-length clone (Rodriguez et al., 2006).  
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Another strategy, used for viruses that prove impossible to clone full-
length, is to clone the genome in two halves, which are maintained 
independently and then recombined in vitro prior to RNA transcription 
using a suitably engineered restriction site (Jakab et al., 1997). This 
improves the stability of the clones, the engineered restriction site can 
be used for recombining different virus strains for gene function 
analysis and also serves as a useful marker for tracing the virus 
through experiments.  
A third alternative is to dispense with cloning altogether and 
generate infectious RNA transcripts directly off full-length PCR 
products that have a suitable recognition site for the T3, T7 or SP6 
RNA polymerase incorporated into the full-length amplification 
primers, for transcript synthesis. This avoids the instability problems 
of cloned full-length clones but limits the extent to which the genomes 
can be manipulated genetically. This approach was successful for 
synthesizing full-length, infectious transcripts of BQCV after it proved 
impossible to successfully clone full-length BQCV (Benjeddou et al., 2002). 
 
5.6.2. Protocol    
Here we describe a method for:  
 Producing full-length PCR products of positive-stranded, 
ssRNA honey bee viruses, with a T7 RNA polymerase 
promoter site incorporated into the forward primer sequence 
(sections 5.6.2.1. – 5.6.2.2.) 
 Cloning this product into a stable plasmid vector (section 
5.6.2.3.) 
 Confirming the integrity and character of the full-length clones 
(section 5.6.2.4.) 
 Synthesizing full-length infectious RNA transcripts of the virus 
(sections 5.6.2.5. – 5.6.2.6.) 
 
5.6.2.1. Full-length reverse transcription 
Genomic RNA of most honey bee ssRNA viruses is approximately 10 kb 
long and contains highly structured 5’-terminal un-translated region 
with extended hairpin structures. Therefore, the first strand cDNA 
synthesis should be performed using a reverse transcriptase with a 
high optimum temperature (e.g. InVitrogen’s Superscript III), so that 
RNA secondary structures are also transcribed. 
1.   Prepare purified virus particles using gradient centrifugation 
(see section 7; “Virus purification") 
2.   Extract viral RNA from the purified virus particles (see section 
8.3.; “Nucleic acid extraction”) 
3.   Combine in a single 200 µl thin wall tube:  
3.1. 1 µg virus RNA, 
3.2. 1 µl 2 µM “Reverse Primer” 5’-CGGTGTTTAAAC(T)27(X)32-
3’, where (X)32 is a sequence complementary to the final 32 
nucleotides at the 3’ end of the virus genome to be cloned, 
3.3. 1 µl 10 mM dNTPs,  
3.4. Make the total volume 13 µl with RNase-free water. 
4.   Mix well by pipetting on ice. 
5.   Incubate at 65°C for 3 minutes in PCR heating block. 
6.   Transfer to ice and cool down for 1 minute. 
7.   Add the following:   
7.1. 4 μl 10x First Strand Buffer (supplied with Superscript III), 
7.2. 1 μl 0.1M DTT,  
7.3. 1 μl RNase OUT recombinant RNAse inhibitor (Invitrogen). 
8.   Mix well and incubate at 52°C for 2 minutes in heating block. 
9.   Add 2 µl Superscript III reverse transcriptase (Invitrogen) and 
mix well.  
10. Incubate at 52°C for 10 min. 
11. Incubate at 55°C for 60 min. 
12. Incubate at 70°C for 15 min. 
13. Store in freezer as a template for full length cDNA amplification. 
 
5.6.2.2. Amplifying full-length viral RNAs 
One critical factor in the successful amplification of viable, full-length 
cDNAs is the use of a thermostable DNA polymerase with proof-
reading capacity. One such high-fidelity, high processivity DNA 
polymerase is Phusion DNA polymerase (New England Biolabs). If the 
fragment is to be cloned into a plasmid vector lacking a T7 or T3 RNA 
polymerase promoter site (required for the synthesis of full-length 
infectious RNA copies), then such a site should be incorporated into the 
5’ amplification primer (e.g. Benjedou et al., 2002; Ongus et al., 2006). 
1.   Combine following in the 200 μl thin wall PCR tube placed on ice:  
1.1. 2 μl of the first strand cDNA reaction,  
1.2. 35 μl sterile nuclease free water, 
1.3. 10 μl of 5x HF Phusion amplification buffer, 
1.4. 1 μl 10mM dNTP mixture, 
1.5. 0.5 μl 2 μM “Reverse primer” (section 5.6.2.1.; step 3.2.) 
1.6. 0.5 μl 2 μM T7 RNA polymerase promoter-tagged  
“Forward primer” 5’-GCTATAATACGACTCACTATAGG(X)20-3’ 
where (X)20 are the first 20 nucleotides at the 5’ end of 
the virus genome 
2.   Mix well by pipetting on ice. 
3.   Add 2 μl (5U) Phusion DNA polymerase. 
4.   Mix by pipetting. 
5.   Place the tube in the thermocycler when the block is 90°C   
 (Hot-start PCR). 
6.   Amplify with the following cycling programme:  
 6.1. 98°C:1 min,  
 6.2. 5x [98°C:15 sec – 52°C:60 sec – 72°C:7 min], 
 6.3. 25x [98°C:15 sec – 55°C:60 sec – 72°C:7 min], 
 6.4. 72°C: 7 min. 
7.  Purify the reaction products with PCR purification kit (Qiagen), 
eluting into 50 μl of water. 
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5.6.2.3. Cloning full-length viral RNAs 
Cloning of long (~10 kbp) PCR products into plasmid vectors may be 
not very efficient. We recommend to using  pCR-XL-TOPO cloning, 
which is vector specifically designed for cloning of large products. This 
vector requires 3’ terminal A overhangs in the PCR products, therefore 
the first stage is the addition of 3’ overhangs to the Phusion- 
generated blunt ends.  
1.   Mix the following: 
1.1. 50 μl purified PCR fragments, 
1.2.  6 μl 10x Taq polymerase buffer, 
1.3.  3 μl 10mM dNTPs, 
1.4.  1 μl Taq polymerase. 
2.   Incubate at 72°C for 10 min. 
3.   Separate the fragments by electrophoresis in 0.8% agarose 
gel in TAE buffer. 
4.   Stain the gel with crystal violet (see InVitrogen TOPO XL PCR 
cloning kit). 
5.   Excise the 10 kb full-length cDNA fragments.  
6.   Extract DNA using the Gel Purification reagents included in the 
TOPO XL PCR Cloning kit (Invitrogen). 
7.   Ligate fragments into the pCR XL TOPO vector by mixing: 
7.1.  4 μl of the purified product (approximately 10 to 50 ng) 
7.2.  1 μl of pCR XL TOPO vector. 
8.   Incubate reaction for 5 min at 25°C. 
9.   Stop reaction by addition of 6x TOPO cloning Stop Solution. 
10. Mix for a few seconds at room temperature and place the 
reaction to ice. 
11. Proceed immediately to transformation of the OneShot 
competent E. coli cells (Invitrogen), following the 
manufacturer’s instructions. 
 
5.6.2.4. Confirmation of full-length clones 
1.   Select the white colonies and transfer to a fresh plate. 
2.   Amplify insert DNA from all colonies using the PCR primers 
and protocols from Section 9.3.3.; “RT-(q)PCR – Protocols”. 
3.   Separate PCR products on gel electrophoresis. 
4.   Isolate clones with inserts > 10kb. 
5.   Prepare plasmid DNA from full-length clones using a Qiagen 
plasmid purification kit and corresponding instructions. 
6.   Sequence the inserts in selected plasmids using a series of 
oligonucleotide primers that are conserved between all known 
variants of the virus. 
7.   Confirm identity of clones through comparing the cloned 
sequences with the published consensus virus sequences. 
 
 
5.6.2.5. Synthesizing full-length viral RNA 
The plasmid can be used as a template for in vitro transcription using 
T7 RNA polymerase.  
1.   Linearize plasmid downstream of the 3’ poly-A sequence with 
PmeI restriction endonuclease. 
2.   Purify the linearized templates with a Qiagen plasmid 
purification kit. 
3.   Synthesize capped in vitro RNA transcripts using 
“mMESSAGEmMAchine” T7 kit (Ambion). 
 
5.6.2.6. Confirmation of Full-length Viral RNA 
The full-length nature and activity of the transcripts is confirmed by  
in vitro translation experiments (Green and Sambrook, 2012), and 
ultimately by infection of pupae through injection with the synthesized 
RNA transcripts (see section 5.4). The infectivity of such transcripts is 
confirmed by comparing virus titres between transcript-inoculated 
pupae with control-inoculated pupae, and by sequencing the new 
virus infection (Benjedou et al., 2002). 
 
 
6. Virus infectivity assays 
Infectivity assays were used before sensitive molecular techniques 
were developed to detect low levels of virus in surveys (Bailey, 1976; 
Bailey et al., 1981; 1983b). These assays take advantage of the fact 
that most bee viruses when injected into adult bees or pupae multiply 
rapidly to high titres that can subsequently be detected by serology 
(Dall, 1987). Dilution series of the extracts provide a measure of 
quantitation. Different viruses develop titre and kill pupae at different 
rates, which can be detected by the ‘breaking’ of the eye-colour 
development in white-eyed pupae (Anderson and Gibbs, 1988; 1989). 
This can provide an early indication of which virus is being multiplied. 
Although labour intensive, infectivity assays can rival the most 
sensitive molecular tests available (Denholm, 1999). One serious 
drawback of honey bee infectivity assays is that often unapparent 
viruses present at very low levels in the assay pupae can also be 
amplified, sometimes by the mere injection of buffer (Bailey, 1967; 
Anderson and Gibbs 1988; 1989). Several important bee viruses 
(ABPV, KBV and SBPV) were discovered this way, as a by-product of 
the propagation of CBPV, AIV and BVX respectively (Bailey et al., 
1963; Bailey and Milne, 1969; Bailey and Woods, 1974; 1977; Bailey 
and Ball, 1991), and the technique may yet prove useful for the 
discovery of other symptomless bee viruses. 
In general terms, the procedures for virus infection infectivity 
assays are the same as for virus propagation. It is especially 
important is that the larvae and pupae are transferred to the 
incubation plate as carefully as possible, and that they are checked for 
vitality and survival before being used for infection experiments. 
Larvae and pupae should be checked under a stereo microscope for 
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damage and vitality. In both cases it is advisable to incubate them for 
12-24 hours prior to conducting the assay, and remove larvae or 
pupae that show signs of necrosis or low vitality. The infectivity 
assays should also include a number of additional methodological 
controls (effects of transfer, incubation, manipulation, feeding etc.), to 
facilitate the interpretation of the data. 
 
 
7. Virus purification 
7.1. Introduction 
The method given below for purifying honey bee viruses is simple but 
only suitable for non-enveloped viruses, which fortunately covers the 
vast majority of RNA viruses. However, this method is unsuitable for 
viruses containing membranes, such as Apis mellifera filamentous 
virus. There are a number of enveloped virus families that have insect
-infecting members and there may be more enveloped honey bee 
viruses to be discovered. The various buffers, solvents and centrifugation 
conditions for purifying individual viruses are given in Table 4. Most of 
the buffers shown are the phosphate buffers developed by Bailey and 
Ball (1991), between 0.01 and 0.5M and of neutral pH (between 7.0 
and 8.0). In most cases, TRIS.Cl buffers of similar molarity and pH 
will perform equally well. Similarly, chloroform can be substituted for 
the more toxic ether/carbon tetrachloride combination for extract 
clarification. Nonionic detergents such as Triton X100 (0.05%), BRIJ-
58 (2%) and/or sodium deoxycholate (0.2%) are also common agents 
for lipid solubilisation and extract clarification during virus purification. 
0.1 M ascorbic acid is a common alternative to DIECA as antioxidant. 
Conduct as much of the purification as possible at 4°C (on ice). With 
each purification step, there is a considerable loss of yield, particularly 
during the high-speed and gradient centrifugation steps. As much as 
80% of the primary extract can be lost during purification. It is 
therefore important to consider how pure the virus preparation needs 
to be for your experiments. For infection experiments, purity may be 
less important while for developing a specific antiserum, high purity is 
essential. The high-speed and gradient centrifugation steps are 
excellent for separating the virus from other cellular contents and 
particles, but are not suitable for separating different virus species: 
they all have very similar densities.  
 
7.2. Protocols 
7.2.1. Primary extract 
1.   Mix 2 ml of extraction buffer (Table 4) per 1 g of bee tissue.  
2.   Prepare a primary virus extract by either: 
  Grinding the bee tissues in liquid nitrogen in a mortar-and-   
    pestle. 
  Liquidizing in an automatic blender. 
  Using a large-volume bead mill.  
(see also section 8.2.; “Sample Homogenisation”) 
3.   Transfer to a solvent-resistant container.  
4.   Add 0.5 ml of chloroform or carbon tetra-chloride per 1 g of 
bee tissue.  
5.   Shake vigorously by hand. 
6.   Centrifuge at 8,000 g and 4°C for 15 minutes. 
7.   Carefully collect the supernatant.  
8.   Discard the organic phase. 
9.   Remove 10 µl for virus analysis by RT-qPCR or ELISA (see 
section 9.3. and the BEEBOOK article on molecular methods 
(Evans et al., 2013) to determine the viral purity of the extract.  
10. The crude extract at this stage is appropriate for long-term 
storage. Add glycerol to a final concentration of 50%, aliquot 
and store at -80°C.   
 
7.2.2. High speed centrifugation 
1.   Centrifuge the supernatant at 75,000 g and 4°C for 3 hours. 
2.   Discard the supernatant.  
3.   Re-suspend the pellet 5 ml extraction buffer.  
This is best achieved by storing the pellet with buffer overnight at 4°C, 
to loosen the pellet.  
4.   Next day vortex the pellet lightly.  
5.   Centrifuge at 8,000 g and 4°C for 15 minutes. 
6.   Retain the supernatant for gradient centrifugation. 
 
7.2.3. Gradient Centrifugation 
The purpose of gradient centrifugation is to concentrate the virus 
particles according to their specific density and thereby separate them 
from other cellular material with different density. For high purity 
requirements, where the virus needs to be separated from other 
particles with similar density (e.g. ribosomes), ‘continuous’ gradients 
are used. These have a gradual transition from high to low density so 
that each particle-type can band at its own specific density. For lower 
purity requirements ‘discontinuous’ gradients can be used. These have 
low density solution layered on top of high density solution, with a 
sharp interface between them where all material with a specific 
density between the high and low solutions concentrates. 
Discontinuous gradients are slightly easier to prepare and to 
fractionate, but continuous gradients are cleaner and more secure if 
the specific density of a virus is not known. Many different substances 
can be used for creating the density differential (sugars, salts, 
polyethylene glycol, synthetic polymers), each with their (dis)
advantages, but for most virus purification purposes sucrose gradients 
are adequate. The most common alternative is CsCl (caesium 
chloride) gradients. These are easier to prepare and generally leave 
cleaner virus preparations, but require longer centrifugation. CsCl is 
also chaotropic, stripping virus particles from other cellular 
constituents, and is therefore not suitable for purifying enveloped 
viruses. For these, sucrose gradients should be used. Gradient 
centrifugation is best done in a high-speed, swing-out rotor. These 
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usually have 6 buckets, which should all be used during each 
centrifugation run, since the rotor is only fully balanced when each 
bucket is present in its correct position. This means that for each run, 
six centrifugation tubes should be prepared and balanced. 
 
7.2.3.1. Sucrose gradients 
1.   Prepare four solutions, containing the appropriate virus  
 extraction buffer (Table 4) and either 10%, 20%, 30% or 
 40% sucrose.  
This is best done by mixing the appropriate amounts of 10x buffer, 
60% sucrose solution and water.   
2.   Divide the total volume of a centrifuge tube by 5.  
3.   Add 1/5th volume of the 10% sucrose-buffer solution to every 
 centrifugation tube.  
Be accurate with the volumes, to avoid problems with balancing the 
tubes later-on. 
4.   Using a syringe with a long needle, layer 1/5th volume of the 
 20% sucrose-buffer solution underneath the 10% solution.  
5.   Repeat with 1/5th volumes of the 30% and 40% sucrose-
 buffer solutions. 
6.   Place the tubes in a freezer with minimum disturbance,. 
7.   Once completely frozen, take the tubes out and thaw  
completely.  
The higher concentration solution will thaw earlier than the lower 
density solutions, causing the boundaries between the concentration 
layers to blur.  
8.   Repeat the freeze-thaw process twice more to extend this 
 process, generating a continuous density gradient.  
Do not freeze-thaw too often, or you will end up with a single-density 
solution. 
9.   For discontinuous gradients, layer 1/5th volume of the 40% 
 sucrose-buffer solution underneath 3/5th volume of the 10% 
 sucrose-buffer solution. 
10. Layer 1/5th volume of virus extract carefully on top of the 
 gradient. 
11. Balance the tubes by weight to within 1 mg, using buffer 
solution.  
12. Insert tubes carefully in the buckets and hang the buckets in 
 the correct orientation in their appropriate place on the rotor. 
13. Centrifuge in a swing-out rotor at the appropriate speed, time 
 and temperature for the virus in question (see Table 4). 
 
7.2.3.2. Caesium chloride gradients 
CsCl gradients can be used either instead of sucrose gradients, or as 
an additional purification step after sucrose gradients. CsCl gradients 
are formed automatically during centrifugation, from a single-density 
solution (isopycnic, or self-forming, gradients). This is a property of 
the heavy salt. 
1.   Resuspend the virus in its buffer (Table 4).  
2.   Make the solution 1.37 g/ml CsCl; final concentration.  
This is the density where most picorna-like viruses will band.  
3.   Centrifuge 28,000 rpm for 16-24 hours at 15°C-20°C.  
Higher centrifugation speeds will create steeper gradients.  
 
7.2.3.3. Fractionation 
1.   After centrifugation, carefully remove the centrifuge tubes 
 from each bucket. 
If there is a lot of virus then the virus particles can be seen as an 
iridescent band underneath a top-light (Figure 3).  
Often two bands can be seen; a lighter band higher in the gradient 
and a more intense band lower in the gradient. These correspond to 
‘empty’ and ‘filled’ (with RNA) particles respectively.    
2.   Remove the band(s) with a disposable syringe and needle. 
This is best done using a needle with a ‘flat’ end, rather than the 
‘angled’ end. Slide the needle along the centrifuge wall to just below 
the band and draw up the band slowly into the syringe. 
3.   If no bands can be seen, either because of low virus amounts 
 or because the centrifuge tube is opaque, then the gradient 
 needs to be fractionated by removing 0.5 ml volumes at a time.  
The best way is to use an automated fractionator, which removes the 
fractions from the bottom of the gradient. The manual alternative is to 
remove 0.5 ml fractions from the top of the gradient. 
4.   Analyse 10 µl of each fraction for the presence of virus, using 
 either ELISA (see section 9.2.) or RT-(q)PCR (see section 9.3. 
 and the BEEBOOK article on molecular methods; Evans et al., 
 2013).  
Since there will be some virus contaminating every fraction, 
qualitative RT-PCR will not be able to distinguish very well between 
high and low virus fractions.  
5.   Pool the 3-4 fractions containing the highest virus 
 concentrations, giving a final volume of approximately 2 ml.  
6.   If necessary, the virus can be concentrated further by another 
 high-speed centrifugation (Table 4), although this will reduce 
 the yield.  
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8. Virus sample processing 
8.1 Introduction 
The primary processing of a sample is crucial for the uniformity of a 
diagnostic method and should be optimized for high yield and low 
variability (Bustin, 2000). There are two main stages: sample 
homogenization and nucleic acid extraction. This section is covered in 
detail in the BEEBOOK article on molecular methods (Evans et al., 
2013), with a reduced version given below. 
 
8.2. Sample homogenisation 
The most variable step in sample processing is sample 
homogenization. Different sample types require different 
homogenization methods (see below), but all should be optimized 
experimentally to ensure minimal variability between replicate 
samples. 
 
8.2.1. Bead-mill homogenizers 
These are mechanical shakers that homogenize samples with glass, 
ceramic or steel beads and give excellent and highly uniform 
homogenization of small samples (1-10 bees).   
 
8.2.2. Blender 
Similar homogenization uniformity to the beadmills, but for large 
samples (50-1000 bees). There is a risk of cross-contamination 
between samples, through re-use of the blender, which should be 
assessed.    
 
8.2.3. Mortar and pestle 
This method is suitable for medium-size samples (10-50 bees) but is 
much less uniform than beadmills or blenders, and also has a cross-
contamination risk due to re-use of the equipment.  
 
8.2.4. Mesh bags 
Mesh bags are a disposable alternative to mortars, also for medium-
size samples (10-50 bees). Homogenization uniformity is also 
moderate, but without the cross-contamination risk.   
 
8.2.5. Micropestle 
These are disposable pestles for manually grinding individual bee 
samples in microcentrifuge tubes. They are much inferior to bead-
mills in terms of homogenization uniformity, for the same samples 
size. At best they should only be used for soft (brood) stages.  
 
8.2.6. Robotic extraction 
Robotic extraction stations are very reliable and consistent, but 
generally only suitable for small sample sizes and soft tissues. They 
are best used after bead-mill homogenization, as part of a semi-
automated homogenization-extraction chain.  
Fig. 3. White translucent band containing DWV particles after CsCl 
density gradient centrifugation.                           Image © E Ryabov. 
 
8.3. Nucleic acid extraction 
A denaturing buffer should be used during homogenization to protect 
the nucleic acids from degradation. The most common denaturants 
used are: high concentrations of chaotropic (guanidine) salts, strong 
antioxidants (β-mercaptoethanol), detergents and/or organic solvents. 
The nucleic acid is purified from the buffer using either cheap, 
disposable affinity purification columns or even cheaper precipitation 
with ethanol, isopropanol or lithium chloride (RNA only). Both 
methods are reliable, though not particularly uniform (Tentcheva et 
al., 2006). Affinity columns generally produce cleaner nucleic acid 
samples, due to the column washing steps. Precipitation can produce 
higher yields, since columns have a limited binding capacity, or 
extract volume, equivalent to ~¼ bee.    
 
8.3.1. Protocol 1 – affinity column purification 
The processing consists of making a primary homogenate from 1-30 
bees and purifying RNA from 100 μl aliquots of the homogenate 
(equivalent to 20 mg bee tissue: the maximum loading capacity of 
one affinity column). The protocol is based on the Qiagen RNA 
purification columns. β-mercaptoethanol is toxic.  
1.   Prepare fresh GITC buffer:  
1.1. 5.25 M guanidinium thiocyanate (guanidine isothiocyanate), 
1.2. 50 mM TRIS.Cl (pH 6.4), 
1.3. 20 mM EDTA, 
1.4. 1.3% Triton X-100, 
1.5. 1% β-mercaptoethanol. 
2.   Place frozen bees in the homogenizer of choice.  
3.   Per bee add the following amount of GITC buffer: 
 
4.  Proceed according to the Qiagen Plant RNA extraction protocol 
using 100 μl extract as sample. The Qia-shredder option 
significantly increases yield and purity of nucleic acid (see 
Qiagen instructions booklet). 
5.   Elute in 100 μl nuclease-free water. 
6.   Determine nucleic acid concentration and purity (see section 
8.4.; “Nucleic acid quality assessment”).  
7.   Store as two separate 50 μl aliquots at -80°C, one for working 
with and one for storage. 
8.   Include a ‘blank’ extraction (i.e. an extraction of purified 
water) after every 24 bee samples, to make sure none of the 
extraction reagents have become contaminated. 
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8.3.2. Protocol 2 – TRIzol extraction and isopropanol 
precipitation 
This protocol uses TRIzol®; a proprietary mixture of phenol and high 
concentration salt solution (InVitrogen). The RNA is recovered 
through isopropanol precipitation.  
1.   Homogenize bees directly at 4°C in TRIzol® reagent in a glass
-walled blender or mortar and pestle. Use 1 ml reagent per 
bee (~120 mg tissue). 
2.   Add 0.5 ml chloroform per bee. 
3.   Shake hard for 1 minute. 
4.   Centrifuge 8,000 g; 15 minutes; 4°C. 
5. Recover the upper (aqueous) layer containing the nucleic 
acids, discarding the lower red (organic) phase and the semi-
solid, white interphase (containing proteins and lipids). 
6.   Add an equal volume of iso-propanol, mix and precipitate at  
-20°C for at least 15 minutes.  
7.   Centrifuge 8,000 g; 15 minutes; 4°C.  
8.   Remove iso-propanol supernatant.  
9.   Resuspend nucleic acid pellets in 100 µl RNase-free water.  
10. Determine nucleic acid concentration and purity (see section 
8.4.; “Nucleic acid quality assessment”).  
11. Store as two separate 50 μl aliquots at -80°C, one for working 
with and one for storage. 
 
8.4. Nucleic acid quality assessment 
A number of sophisticated methods are available to determine the 
quantity, quality and integrity of an RNA sample, as described in the 
BEEBOOK paper on molecular methods (Evans et al., 2013). The 
minimum requirements are to determine the yield of the RNA, and its 
purity with respect to protein and phenolic metabolite contaminants. 
This can be determined by UV spectrophotometry (Green and 
Sambrook, 2012), through comparing peak absorbance at 260 nm 
(nucleic acids), 280 nm (proteins) and 230 nm (phenolic metabolites):  
 A260 of 1.0  = 40 ng/μl ssRNA 
   = 37 ng/μl ssDNA 
   = 50 ng/μl dsDNA 
 A260/A280 < 2.0 indicates contamination with proteins. 
 A260/A230 < 2.0 indicates contamination with phenolics.    
 
 
9. Virus detection 
9.1. Introduction 
There are numerous techniques available for detecting and 
quantifying viruses (de Miranda, 2008; see also the BEEBOOK paper 
on molecular methods (Evans et al., 2013). Most of these detect only 
a small portion of the viral genome or the capsid proteins, and almost 
all require some sort of amplification, either of the target (most of the 
Bee Weight Buffer Total volume 
Worker bee 120 mg 500 μl 600 μl 
Drone 180 mg 700 μl 900 μl 
Worker pupa 160 mg 650 μl 800 μl 
Drone pupa 240 mg 1000 μl 1200 μl 
nucleic acid-based detection technologies) or the detection signal 
(most of the protein-based detection technologies). Both are 
important considerations to bear in mind when interpreting virus 
diagnostic data. Here we will only cover the most commonly used 
methods. 
Secondly, despite the popular classification of molecular assays as 
either ‘qualitative’ (presence/absence) or ‘quantitative’ (concentration), 
ultimately all assays are quantitative: qualitative assays are simply 
quantitative assays with a detection threshold (a visible colour; a band 
on a gel; a fluorescence level; a Cq value; a statistical index). This is 
an important consideration, since there are many factors besides the 
initial virus amount that can influence whether or not an assay 
reaches a detection threshold, such as degradation of the sample, 
changes to storage-extraction procedures, assay deterioration etc.. 
Furthermore, the molecular and mathematical rules underpinning any 
assay are the same whether this assay is ‘qualitative’ or ‘quantitative’. 
The only difference is that in ‘quantitative’ assays these rules are 
specifically acknowledged and accounted for, whereas in ‘qualitative’ 
assays they are often ignored. It is therefore advisable to approach 
any experiment or assay from a quantitative perspective first, and 
include the appropriate controls for threshold-conversion to 
‘qualitative’ data, if this is desired. 
 
9.2. Enzyme-Linked ImmunoSorbent Assay (ELISA) 
There are many versions of the ELISA, using different blocking 
agents, primary/secondary antibodies, reporter enzymes and their 
specific colorimetric substrate solutions for detection and 
quantification (Harlow and Lane, 1988). They generally fall into one of 
two major categories: 
  
9.2.1. Normal ELISA 
In conventional ELISA, the sample is adsorbed directly into the wells, 
to be detected by the specific antibody. This antibody is either 
conjugated directly to an enzyme (Fig. 4A), usually either horse radish 
peroxidase or alkaline phosphatase, or more commonly is detected in 
a subsequent incubation by a commercial enzyme-conjugated protein 
that recognizes antibodies in general (Fig. 4B). 
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9.2.2. Sandwich ELISA 
In “sandwich” ELISA, a modified version of the primary antibody is 
adsorbed to the well first, in order to ‘capture’ the virus particles after 
the sample is added. The captured virus particles are then detected as 
before, either with the reporting enzyme directly conjugated to the 
detecting antibody (Fig. 4C) or with an extra incubation using an 
antibody-detecting protein conjugated to the reporter enzyme (Fig. 4D). 
The sandwich ELISA is cleaner and much more sensitive than conventional 
ELISA, but has a less predictable relationship between virus concentration 
and signal (depending on which component in the assay is limiting).  
The most common reporter enzyme systems are horseradish 
peroxidase (HRP) and alkaline phosphatase (AP). Both are relatively 
robust enzymes that can be conjugated to the primary or secondary 
antibody. They convert a colourless substrate into a coloured reaction 
product, such that the absorbance at a wavelength appropriate for the 
specific colour produced is proportional  to the amount of enzyme 
activity present in the sample, which in turn is proportional to the 
amount of antibody captured by the sample, and thus also the 
amount of virus in the sample. The protocols below are generic ones 
for conventional ELISA and sandwich ELISA, based on the methods of 
Allen et al. (1986), using horseradish peroxidase as the reporter 
enzyme. See also Harlow and Lane (1988) for alternatives and more 
extensive laboratory protocols involving antibodies. 
 
9.2.3. Protocols 
9.2.3.1. Sample preparation 
1.   Mix phosphate-buffered saline (PBS): 
1.1. 0.8% NaCl, 
1.2. 0.14% Na2HPO4.2H2O, 
1.3. 0.02% KH2PO4, 
1.4. 0.02% KCl, 
1.5. Adjust to pH 7.4. 
2.   Grind each bee in 1 ml PBS. 
3.   Add 300 µl chloroform. 
4.  Mix on a vortex. 
5.   Centrifuge for 3 minutes to clarify. 
 
 
Fig. 4. Different types of ELISA, depending on whether the antigen1 is adsorbed directly onto the assay well (A & B) or is captured by the Fab 
fragment of a specific antibody4 or the full antibody5  (sandwich ELISA; C & D) and whether the detection system involves an enzyme reporter 
conjugated directly to the detecting antibody6 (A & C) or a reporter conjugated to a generic antibody-recognizing protein3 recognizing the 
detecting antibody2 (B & D). Adapted from de Miranda (2008). 
9.2.3.2. ELISA 
1.   Mix coating buffer (CB): 
1.1. 0.159% Na2CO3, 
1.2. 0.293% NaHCO3, 
1.3. Adjust to pH 9.6. 
2.   Seed each well with 180 µl of CB. 
3.   Add 5-20 µl sample. 
4.   Incubate 3 hrs at ambient temperature, or overnight at 4°C.  
5.   Tip out and wash the wells 3X with PBS-T (= PBS containing 
0.05% Tween20 detergent), shaking the ELISA plate dry each 
time. 
6.   Prepare a 1/2,000 - 1/5,000 dilution of the primary antibody 
in PBS-TPO:  
6.1. 2% Polyvynylpyrrolidone (PVP) mw 440000, 
 6.2. 0.2% Bovine serum albumin (BSA),  
6.3. in PBS-T (fresh daily). 
7.   Add 200 µl of antibody/PBS-TPO to each well. 
8.   Incubate 3 hrs at ambient temperature, or overnight at 4°C. 
9.   Tip out fluid and wash the wells 3X with PBS-T, shaking the 
ELISA plate dry each time. 
10. Prepare a ProteinA-HorseRadishPeroxidase (PrA-HRP) 
conjugate stock solution at 100 µg/ml. 
11. Make a 1/2,000 – 1/5,000 dilution of PrA-HRP stock solution in 
PBS-TPO. 
12. Add 200 µl to each well.  
13. Incubate 3hrs at ambient temperature, or overnight at 4°C.  
14. Tip out fluid and wash the wells 3X with PBS-T, shaking the 
ELISA plate dry each time. 
 
9.2.3.3. Sandwich ELISA 
1.   Seed each well with 200 µl of a 1/2,000-1/5,000 dilution of 
the Fab fragment (Harlow and Lane, 1988) of the primary 
antibody in coating buffer (CB, see section 9.2.3.2.). 
2.   Incubate 3hrs at ambient temperature, or overnight at 4°C.  
3.   Tip out and wash the wells 3X with PBS-T, shaking the ELISA 
plate dry each time. 
4.   Add 180 µl PBS-TPO to each well. 
5.   Add 20 µl sample to each well. 
6.   Incubate 3hrs at ambient temperature, or overnight at 4°C.  
7.   Tip out fluid and wash the wells 3X with PBS-T, shaking the 
ELISA plate dry each time.  
8.   Add 200 µl 1/2,000 – 1/5,000 dilution of PrA-HRP stock 
solution in PBS-TPO to each well.  
9.   Incubate 3hrs at ambient temperature, or overnight at 4°C.  
10. Tip out fluid and wash the wells 3X with PBS-T, shaking the 
ELISA plate dry each time. 
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9.2.3.4. Development 
The development of the enzymatic reaction is the same for 
conventional and sandwich ELISA. This method is appropriate for 
horseradish peroxidase as a reporter enzyme. A different substrate is 
required if alkaline phosphatase is used as the reporter enzyme 
(Harlow and Lane, 1988), together with a different wavelength for 
determining the absorbance, but the overall procedure is the same.  
1.   Prepare TMB substrate solution: 
1.1. 100 ml water, 
1.2. 1 ml 10 mg/ml TMB (33’55’TetraMethylBenzidine) in 
DMSO (DiMethylSulfOxide), 
1.3. 10 ml 1M Na Acetate (pH 5.8 with 1.0M citric acid), 
1.4. 20 µl 30% H2O2. 
2.   Add 200 µl substrate solution to each well. 
3.   Let colour develop for 10-15 minutes . 
4.   Add 50 µl 3M H2SO4 to terminate the reaction. 
5.   Immediately read the absorbance at 450 nm (the 
termination reaction will continue to develop colour). 
 
9.2.3.5. Controls 
ELISA is a complex, multistep assay involving sensitive enzymatic 
reporters, which means that there are many opportunities for assay 
failure, either through false-positive or false-negative results. 
Enzymatic reporter systems, such as used by ELISA, are sensitive to 
any native enzymatic activity present in the sample (peroxidases, 
phosphatases). The initial coating step in a highly alkaline buffer 
abolishes most of such background activity, as does the specific 
capture of virus particles in sandwich ELISA and the washes with PBS. 
However, the user should be aware of the possibility of residual 
enzymatic activity in the samples, particularly if the substrate 
incubation step is extended to allow more colour to develop (for 
instance, when trying to detect very low amounts of virus). Secondly, 
either the enzyme or the substrate may be faulty, preventing colour 
development even though there has been antibody recognition of the 
sample. Alternatively, the primary or secondary antibody may fail, for 
a number of reasons. All ELISA assays should therefore have a 
number of controls to establish the correct functioning of the assay 
itself, thus validating the results from the samples.  
 
 Reporter-free negative control (quantification of background 
substrate absorbance). 
 Sample-free negative control (Absence of non-specific binding 
of antibodies/reporters to wells; test of blocking and washing 
efficacy). 
 Primary antibody-free negative control (Absence of non-
specific binding of secondary antibody and/or reporters). 
 Secondary antibody/reporter-free negative control 
(quantification of background enzymatic activity in samples). 
 Substrate-free negative control (quantification of background 
absorbance in the system). 
 Primary antibody positive control (direct adsorption of 
antibody in CB: test for recognition of antibody by secondary 
antibody-reporter). 
 Secondary antibody positive control (direct adsorption of 
secondary antibody-reporter in CB: test for functioning 
reporter enzyme). 
 Purified virus positive control (correct recognition of virus by 
primary antibody; calibration standards). 
 
9.3. RT-(q)PCR 
The most common current methods for honey bee virus detection are 
based on Reverse Transcription Polymerase Chain reaction (RT-PCR), 
essentially the PCR amplification of cDNA. A detailed coverage of the 
principles and practices of PCR is found in Yuryev (2007) and the 
BEEBOOK paper on molecular methods (Evans et al., 2013). A reduced 
version, including those elements specifically relevant to virus detection, 
is presented here. 
 
9.3.1. Primer design 
Designing RT-(q)PCR assays for detecting (honey bee) RNA viruses 
poses some unique challenges. The most critical components of a PCR 
assay are the two amplification primers. RNA viruses are genetically 
highly variable while PCR is very sensitive to nucleotide mismatches 
between primer and target, particularly at the 3’ primer termini where 
extension occurs (Onodera, 2007). A mismatch at the 3’ terminus of 
just one of the primers will result in non-amplification. Mismatches 
further away from the 3’ terminus have increasingly less influence on 
the success of amplification and generally only the last two 3’ 
nucleotides are critical for amplification specificity. The 3’ mismatch 
issue is therefore crucial to the specificity, accuracy, reliability and 
sensitivity of a PCR-based virus assay. Here we outline how to use 
this to our benefit, and how to avoid it when needed.  
 
9.3.1.1. What do we want to detect? 
The first decision is to establish precisely what the assay should 
detect and what it should not detect:  
 For distinguishing closely related strains, locate the 3’ 
terminus of one primer at a position where the strains differ 
consistently. The other primer can be common for all strains 
(de Miranda et al., 2010b).  
 For detecting all potential variants within a virus species or 
complex, the primer sequences should be conserved between 
all known variants, so as to be able to detect both known and 
as-yet-unknown variants in the complex. Locate the primers 
at least 200 nucleotides apart, so that new variants can be 
identified by sequence analyses of the intervening region.   
 Avoid locating the 3’ terminus of a primer on the 3rd base of a 
codon in the coding region of a virus genome, since these are 
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by far the most variable nucleotides in any virus genome 
(Grabensteiner et al., 2001; Bakonyi et al., 2002b; de Miranda 
et al., 2004; Lanzi et al., 2006; Olivier et al., 2008; de 
Miranda et al., 2010b). 
 Use deoxyinosine as the 3’ nucleotide, which can pair with all 
nucleotides (Benjeddou et al., 2001; Topley et al., 2005), thus 
avoiding the 3’ mismatch problem altogether. 
 
9.3.1.2. Where in the genome? 
The genome of positive-strand RNA viruses is usually compact and 
efficiently coded, and there is normally no duplication of sequences 
within the genome. This facilitates the assay design enormously, since 
one can choose between many alternative assays on virological and 
assay performance-quantitation criteria, no matter where in the 
genome they are located, since they should all only amplify a single 
region of the genome. 
 
9.3.1.3. Primer annealing temperature, length and 
composition 
Both amplification primers should have similar melting temperature 
(Tm), length and composition. It is useful to design all assays and primers 
around the same annealing temperature, so that a single cycling 
program can be used for all assays, and that different assays can be 
run concurrently with the same program, on the same plate. 56°C is a 
good, standard, robust target for the in silico estimated Tm for primers.  
 
9.3.1.4. Primer-dimer and other PCR artefacts  
PCR is susceptible to qualitative and quantitative errors caused by the 
accidental, and highly efficient, amplification of short non-target PCR 
templates formed by fleeting complementarity of the primers with non
-target templates, or among the primers themselves (SantaLucia, 
2007; see the BEEBOOK paper on molecular methods; Evans et al., 
2013). Such artefacts can be identified by gel electrophoresis during 
assay optimization. The easiest solution to persistent PCR artefacts is 
to design new primers and test these experimentally (SantaLucia, 2007).  
 
9.3.1.5. Fragment length 
PCR assay design software packages usually design very short 
amplicons (< 100 nucleotides), with high amplification efficiency and 
short cycling times. However, amplicons up to 300 nucleotides amplify 
equally efficiently but are easier to separate from PCR artefacts, 
provide more room for designing probes and can be used to 
characterize new variants, through sequence analyses.  
 
9.3.2. Detection and analysis of PCR products 
9.3.2.1. “End-point” vs “real-time” detection  
The PCR products can be detected after the PCR is completed, usually 
for “qualitative” analysis (presence/absence of product), either by 
(gel) electrophoresis or Melting Curve analysis. Detection can also be 
done after each cycle, as PCR proceeds, using laser optics (i.e. in ‘real
-time’). The amount of initial target cDNA in a reaction can then be 
very accurately related to how many amplification cycles are required 
for a product to appear. This is the basis for “quantitative” PCR 
(qPCR), which is extremely accurate over a wide range of target 
concentrations (see the BEEBOOK paper on molecular methods; 
Evans et al., 2013). 
 
9.3.2.2. Cycles and thresholds 
Continuous real-time detection also allows multiple detection 
thresholds (i.e. the cycle at which product appears) to be set for the 
same reaction, which can be related to different levels of risk for 
disease. For most practical (or even experimental) purposes, 35 cycles 
of amplification is sufficient. Beyond 35 cycles, the rapidly increasing 
risk of both false-positive and false-negative detection errors 
outweighs the marginal gains in sensitivity (see the BEEBOOK paper 
on molecular methods; Evans et al., 2013). 
 
9.3.2.3. Detection chemistry 
There are many different detection chemistries available for following 
qPCR in real-time (de Miranda, 2008). The two most common are 
SYBR-green and similar DNA-binding dyes, and fluorophore-labelled 
hydrolysis (TaqMan™) probes. The merits of both systems are 
discussed in the BEEBOOK paper on molecular methods (Evans et al., 
2013). TaqMan™ assays are best suited for well-optimized, stable 
assays for widespread, routine diagnosis. SYBR-green assays are 
better suited for discovery, characterization of new strains and 
analysis of strain mixtures (Papin et al., 2004). They are also much 
cheaper to design, adapt and optimize (Bustin and Nolan, 2004).  
 
9.3.3. Assay optimization 
Once a PCR assay has been designed, it should be optimized 
experimentally for annealing temperature (using annealing 
temperature gradients), primer concentration and cycling times (see 
the BEEBOOK paper on molecular techniques; Evans et al., 2013). 
Optimization usually identifies the highest annealing temperature, the 
lowest primer concentrations and the shortest incubation time that 
consistently generates the right product, without artefacts, at a 
consistent amplification cycle (see section 12: “Quality control”). 
 
9.3.3.1. Reverse transcription 
Reverse transcription is the most variable step in RT-PCR, whose 
efficiency is easily affected by inhibitors, reaction conditions (including 
primers) and even nucleic acid concentration (Ståhlberg et al., 2004a; 
2004b). To minimize this variability, the nucleic acid should be 
optimally prepared and a constant amount used in every reaction. 
Since PCR does not require large amounts of initial target, the RNA 
can be diluted to minimise the effects of any inhibitors. cDNA is best 
prepared with random hexamer primers that generate a bias-free 
cDNA copy of the entire RNA population, suitable for a multitude of 
analyses.  
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9.3.3.2. One-Step/Two-Step RT-PCR 
Reverse transcription and PCR can be conducted in a single buffer, PCR 
following reverse transcription (One-Step RT-PCR) or in two separate 
reactions (Two-Step RT-PCR). The advantages of One-Step RT-PCR 
are speed and reduced contamination risk; the disadvantages are waste-
ful use of precious RNA and inability to control for differences in cDNA 
synthesis efficiency between reactions (Bustin, 2000; Bustin et al., 2009). 
These (dis)advantages are reversed for Two-Step RT-PCR, with the 
additional advantage that the cDNA produced can be used for many other 
purposes as well. Two-Step RT-PCR also tends to be considerably more 
sensitive and more prone to artefacts, unless steps are taken to avoid 
this (see the BEEBOOK paper on molecular methods; Evans et al., 2013).  
 
9.3.4. Protocols 
Numerous qualitative and quantitative RT-(q)PCR protocols have been 
published for honey bee viruses (Annex 1: http://www.ibra.org.uk/
downloads/20130805/download), although few have been optimized 
experimentally. The European Reference Laboratory for bee diseases 
at ANSES (France) is in the process of designing fully optimized, 
validated RT-qPCR protocols for all bee viruses (see Blanchard et al., 
2012) for routine, standardised diagnostic use by accredited 
laboratories. For experimental purposes, existing published protocols 
can be used and optimized, many of which can be easily adapted to 
qPCR using SYBR-green dye detection. Alternatively, new protocols 
can be designed based on the following practical, robust protocols for 
Reverse Transcription, One-Step RT-qPCR and Two-Step RT-qPCR, 
suitable for either quantitative or qualitative analyses. These provide a 
useful basis for individual adaptation and optimization, using the 
guidelines given above and in the BEEBOOK paper on molecular 
techniques (Evans et al., 2013).  
 
9.3.4.1. Reverse transcription 
The following is a robust, standard reverse transcription protocol for 
generating cDNA that is fully representative of the original RNA 
population: 
 
1.   Mix: 
1.1. 0.5 μg sample RNA template,  
1.2. 1 ng exogenous reference RNA (e.g. Ambion RNA250), 
1.3. 1 µl  50 ng/μl random hexamers,  
1.4. 1 µl 10mM dNTP,  
1.5. up to 12 µl RNAse free water. 
2.   Heat the mixture to 65°C for 5 min and chill quickly on ice. 
3.   Add: 
3.1. 4 μl 5X First-Strand Buffer, 
3.2. 2 μl 0.1 M DTT, 
3.3. 1 μl (200 units) of M-MLV RT. 
4.   Mix by pipetting gently up and down.  
5.   Centrifuge briefly to collect the contents at the bottom of the 
tube. 
6.   Incubate 10 min at 25°C. 
7.   Incubate 50 min at 37°C. 
8.   Inactivate the reaction by heating 15 min at 70°C. 
9.   Dilute the cDNA solution tenfold with nuclease-free water 
before using in PCR assays, to reduce the risk of PCR 
artefacts. 
 
9.3.4.2. Two-Step RT-qPCR 
The following is a robust, standard qPCR protocol for amplifying and 
quantifying cDNA templates < 300bp in length. The protocol is based 
on SYBR-green detection chemistry, with modifications for probe-
based detection and qualitative PCR indicated: 
 
1.   Mix: 
1.1. 3 μl cDNA (pre-diluted 1/10, in nuclease-free water), 
1.2. 0.6 µl 10 μM Forward primer (0.3 μM final concentration), 
1.3. 0.6 µl 10 μM Reverse primer (0.3 μM final concentration), 
[1.4. 0.4 µl*10 μM TaqMan™ probe* (0.2 μM final 
concentration*)], 
1.5. x µl *TwoStep Buffer* + dNTP(0.2 mM final dNTP), 
1.6. y µl nuclease-free water, 
1.7. z µl Thermostable DNA polymerase mix,  
1.8. 20 µl total volume. 
 
* Use appropriate buffer for either SYBR-green or TaqMan™ probe 
assays. dNTP is usually included in pre-optimized buffers. If not, add 
separately to 0.2 mM final concentration.  
2.   Incubate in real-time thermocycler: 
 2.1. 5 min:95°C,  
 2.2. 35 cycles [10 sec:95°C - 30 sec:58°C - read].  
3.   For SYBR-green assays, follow with Melting Curve analysis: 
 3.1. 1 min:95°C, 
 3.2. 1 min:55°C, 
 3.3. 5 sec:0.5°C:read from 55°C to 95°C. 
4.   For qualitative PCR, a conventional thermocycler can be used 
and the products can be analysed by gel, capillary or chip-
based electrophoresis. 
 
9.3.4.3. One-Step RT-qPCR 
The following is a robust, standard One-Step RT-qPCR protocol for 
amplifying and quantifying targets < 300bp in length, using SYBR-
green detection chemistry, and starting with an RNA template: 
 
1.   Mix: 
1.1. 3 μl 5 ng/ μl RNA, 
1.2. 0.6 µl 10 μM Forward primer (0.3 μM final concentration), 
1.3. 0.6 µl 10 μM Reverse primer (0.3 μM final concentration), 
[1.4. 0.4 µl*10 μM TaqMan™ probe* (0.2 μM final 
concentration*)], 
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1.5. x µl *OneStep Buffer* + dNTP(0.2 mM final dNTP), 
1.6. y µl nuclease-free water, 
1.7. z µl Reverse Transcriptase/Thermostable DNA polymerase 
mix, 
1.8. 20 µl total volume. 
 
* Use appropriate buffer for either SYBR-green or TaqMan™ probe 
assays. dNTP is usually included in pre-optimized buffers. If not, add 
separately to 0.2 mM final concentration. 
2.   Incubate in real-time thermocycler:  
  2.1. 15 min:50°C,  
  2.2. 5 min:95°C, 
2.3. 35 cycles [10 sec:95°C - 30 sec:58°C - read].   
3.   For SYBR-green assays, follow with Melting Curve analysis: 
 3.1. 1 min:95°C, 
 3.2. 1 min:55°C, 
 3.3. 5 sec:0.5°C:read from 55°C to 95°C. 
4.   For qualitative PCR, a conventional thermocycler can be used 
and the products can be analysed by gel, capillary or  
chip-based electrophoresis. 
 
9.3.5. Quantitation controls 
A number of controls are required for quantifying the amount of virus 
in a sample. These can be broadly divided into “external reference 
standards”, which are used to quantify the absolute amount of target 
in each reaction, and “internal reference standards”, which are used 
to correct the quantitative data for unique differences between 
individual samples. The BEEBOOK paper on molecular methods (Evans 
et al., 2013) describes in detail the function, preparation and 
application of these standards.  
 
9.3.5.1. External reference standards 
These consist of dilution series of known concentrations of (cloned) 
target DNA or RNA, which is used to establish a calibration curve for 
converting RT-qPCR data to absolute amounts of target (genome 
copies) in a reaction (Pfaffl and Hageleit, 2001; Bustin et al., 2009). 
External reference standards should be prepared for every target 
assayed, including all internal reference standards.  
 
9.3.5.2. Internal reference standards 
Unfortunately, external standards cannot correct for factors unique to 
each sample that affect the RT and/or PCR reactions, such as RNA 
quality and quantity, enzyme inhibitors, sample degradation, internal 
fluorescence etc. To correct for these factors, internal reference 
standards are used. These come in two forms:  
“Exogenous internal reference standard”, which is a pure, 
unrelated RNA of known concentration that is added to the RT 
mastermix prior to RT-qPCR (Tentcheva et al., 2006). The amount 
used should be < 1% of the amount sample RNA, so as not to affect 
the RT-qPCR reaction efficiencies. These are used to calculate cDNA 
reaction efficiencies of individual samples (correcting for RT inhibitors).  
“Endogenous internal reference standards” (commonly called 
‘housekeeping genes’), are relatively invariant host mRNAs present in 
every sample. These can be used to normalize quantitative data for 
differences between samples in RNA degradation or the presence of 
inhibitors (Bustin et al., 2009; Radonić et al., 2004) and to guard 
against ‘false-negative’ data (due to RNA degradation).  
There are a couple of practical difficulties with endogenous 
internal reference standards. First, one can never be certain that they 
are truly invariant (Radonić et al., 2004). The current 
recommendations are therefore to use an index of 3 or 4 endogenous 
reference standards for data correction (Bustin, 2000). Second, 
contaminating genomic DNA in an RNA sample can interfere with 
accurate quantification of the endogenous gene mRNA. This can be 
avoided by digesting the RNA sample with DNAse prior to RT-PCR, or 
more elegantly by designing intron-spanning primers for the endogenous 
reference gene (Bustin, 2000; Yañez et al., 2012; Locke et al., 2012), 
such that only cDNA to the mRNA can be amplified. 
Internal reference standards are costly, since they are run for all 
samples. Their inclusion should therefore be evaluated in relation to 
their importance to the project. There are probably more relevant for 
fully-quantitative experiments and less for semi-quantitative surveys.  
 
9.3.6. Multiple assays 
With careful primer design (see section 9.3.1.) it should be possible to 
approach 100% correct detection (no false positive or false negative 
results) for most viruses with a single primer pair. This is, however, 
very much conditional on the natural variation and variability (i.e. the 
capacity to generate new variants) for each virus. There are valid 
arguments that PCR is perhaps too specific for the reliable detection 
of highly variable entities such as RNA viruses, even when employing 
several different primer sets (Gardner et al., 2003). When the 
reliability of a primer set with respect to virus variability is in doubt, 
the best resolution is to employ several primer sets in parallel so that 
the failure of one set does not necessarily result in misdiagnosis. 
Multiple primer sets also allows one to estimate the rate of 
misdiagnosis by different primer sets due to virus variability (Chui et 
al., 2005). Within the honey bee viruses, multiple primer sets may be 
needed for reliable diagnosis within the highly variable ABPV complex 
(de Miranda et al., 2010a) and the slightly less variable DWV-VDV-1 
complex (de Miranda and Genersch, 2010). Multiple assays are 
available for most honey bee viruses, and comparisons of multiple 
assays have been made for SBV (Grabensteiner et al., 2001), ABPV 
(Bakonyi et al., 2002a; 2002b) and DWV (Genersch, 2005). 
 
9.3.7. Multiplex RT-(q)PCR 
Multiplex RT-PCR refers to the simultaneous amplification of several 
targets in the same reaction. The different end-products are usually 
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identified by size, through (gel) electrophoresis. Several such 
qualitative multiplex protocols have been designed for honey bee 
viruses (Chen et al., 2004b; Topley et al., 2005; Grabensteiner et al., 
2007; Weinstein-Texiera et al., 2008; Meeus et al., 2010). Real-time 
qPCR can also be multiplexed, usually for the simultaneous 
amplification of a target and internal reference standards, by using 
TaqMan™ probes with different fluorophores.  
The main reason for multiplexing is to save cost and time. 
However, multiplex PCR is less sensitive than uniplex PCR, more 
complex to optimize, more prone to artefacts and requires post-PCR 
fragment analysis, nullifying any gains in time and cost. Most 
importantly, the late amplification of low-abundance targets is 
strongly affected by the prior amplification of high-abundance targets, 
through the auto-inhibition of the PCR by the DNA it produces 
(SantaLucia, 2007). For these reasons, it is often more effective to 
use uniplex RT-PCR, even for large projects.  
 
9.4. Microarrays 
Multiplexing is far more effective through a microarray, which is an 
ordered array of hundreds of molecular probes specific for different 
target RNAs bound to a solid support, usually a slide. Most microarray 
technology has been developed for nucleic acid probes, although 
protein-based arrays are also being developed (Sage, 2004). The 
hybridization of RNA target sequences to these probes to these 
probes can be detected by a variety of methods (de Miranda, 2008), 
including PCR and sequencing. Numerous honey bee microarrays have 
been designed, including honey bee immune gene-pathogen arrays 
(Evans, 2006; Runckel et al., 2011) and a honey bee virus array 
(Glover et al., 2011). Microarrays are being superseded for research 
purposes by high-throughput sequencing technologies, but retain a 
future in routine screening applications, due to their adaptability and 
high multiplexing capacity (Glover et al., 2011). See also the 
microarray section in the BEEBOOK paper on molecular methods 
(Evans et al., 2013). 
 
 
10. Virus replication 
10.1. Introduction 
The detection of viral replication is crucial for differentiating between 
an active infection and just the presence of virus particles in a host, or 
between a mechanical (virus non-replicating) and a biological (virus 
replicating) vector of a virus. Evidence that a virus is actively infecting 
a host includes the presence of viral particles and structures within 
host cells, revealed by electron microscopy, preferably including a 
specific nucleic acid or serological probe to positively identify the 
virus. Another approach is to detect the non-structural proteins 
involved in virus replication, which for most positive-stranded RNA 
viruses are only produced after invasion and mark the start of a 
replication cycle. Negative-stranded RNA viruses often carry their 
replicative proteins within the particle. A related philosophy, which is 
more sensitive and accessible, is to specifically detect the replicative 
strand RNA of a virus. Most of the described bee viruses are single- 
and plus-strand RNA viruses which replicate through a negative-
strand RNA intermediate serving as template for the generation of 
new viral plus-strand RNA genomes. The specific detection of viral 
negative strand RNAs can therefore serve as a marker of active 
replication of these RNA viruses in a certain host, tissue or cell type. 
Below are outlined two methods for strand-specific detection of RNA 
virus sequences.  
 
10.2. Strand-specific RT-qPCR 
One of the most popular methods in bee virology for detecting virus 
replication is the specific detection of negative strand viral RNA, using 
strand-specific Reverse Transcriptase-PCR (Peng et al., 2012; DiPrisco 
et al., 2011; Boncristiani et al., 2009; Dainat et al., 2009; Eyer et al., 
2009; Gisder et al., 2009; Celle et al., 2008), following its first 
application in bee virology by Yue and Genersch (2005). The 
procedure is illustrated in Fig. 5, including the most common cause of 
false-positive results (non-specific cDNA synthesis) and how best to 
avoid this (tagged-cDNA primer followed by tag-specific PCR).   
Theoretically, strand-specificity can be achieved by performing the 
reverse transcription reaction in the presence of only one primer 
specifically annealing with a unique region of the viral negative strand 
before amplifying the obtained cDNA by adding the second primer or 
a specific primer pair for PCR amplification. Unfortunately, strand-
specific RT-PCR is highly susceptible to false positive results (Gunji  
et al., 1994; Lanford et al., 1995; Lanford et al., 1994; McGuiness et al., 
1994; Craggs et al., 2001; Peyrefitte et al., 2003; Boncristiani et al., 
2009) due to:  
 False-priming of the incorrect strand by the cDNA primer.  
 Self-priming of positive-strand RNA in areas of complex 
secondary structures. 
 Random priming by contaminating cellular nucleic acids.  
 Incomplete inactivation of the reverse transcriptase, leaving 
residual activity during PCR amplification (which contains both 
negative and positive strand primers).  
To overcome these drawbacks and improve the specificity of the 
assays, certain effective techniques have been developed that 
enhance strand-specificity. These include:  
 Thermostable reverse transcriptases. 
 Tagged-cDNA primers. 
 Inactivation/removal of residual tagged-cDNA primers prior to 
PCR. 
 Chemical blocking of free 3’ ends before or after reverse 
transcription. 
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10.2.1. Thermostable reverse transcriptases 
Thermostable reverse transcriptases, operating at temperatures up to 
50-70°C, avoid much non-specific priming of the RNA through 
elevated reaction temperatures (Lanford et al., 1995; Laskus et al., 
1998; Craggs et al., 2001; Horsington and Zhang, 2007; Carrière  
et al., 2007; Celle et al., 2008). Thermostable reverse transcriptases 
need to be inactivated thoroughly prior to the PCR step, otherwise the 
reverse transcriptase has access to primers for both strands (thus 
nullifying the strand-specificity). Another strategy is to inactivate the 
(viral) RNA by alkaline treatment or digestion with RNase H 
(McGuiness et al., 1994), thereby removing any target for reverse 
transcription during PCR.  
When using thermostable reverse transcriptase, make sure that 
the virus-specific portion of the tagged cDNA primer has a theoretical 
Tm ~60°C, to ensure adequate priming at elevated temperatures. 
 
10.2.2. Chemical blocking of RNA 3’ ends 
The free 3’ ends of the RNA can be blocked with borohydride, so that 
the RNA cannot serve as a primer for cDNA synthesis by self-priming 
or random priming with small cellular RNAs. This means that only RNA 
primed with the strand-specific cDNA primers can be elongated by the 
reverse transcriptase (Gunji et al., 1994). The protocol involves 
oxidation of the RNA free ends with sodium periodate (NaIO4) 
followed by reduction with sodium tetrahydroborate (NaBH4).  
 
10.2.3. Tagged cDNA primers 
To further improve strand-specific detection of viral RNA, tagged RT-
PCR can be used (Craggs et al., 2001). This method relies on a primer 
for cDNA synthesis which contains a tag sequence at the 5’-end that 
is unrelated to either virus or host. PCR amplification is then carried 
out with a primer consisting of only the tag sequence, together with a 
virus-specific upstream primer. This ensures that only cDNA’s derived 
from the tagged cDNA primer are amplified, and not cDNAs from  
false-, self- or mis-priming events. It is therefore important to ensure 
that the chosen tag sequence does not show any homology with a 
known bee pathogen or invertebrate sequence, by checking the tag 
sequences against the nucleotide sequence databases available on the 
NCBI website, using BLAST (Altschul et al., 1990). Tag sequences 
screened for use with honey bee viruses are shown in Table 5.  
 
10.2.4. Removal of tagged-cDNA primers from the cDNA 
reaction 
Since the purpose of using tagged-cDNA primers is to amplify only 
with the tag sequence, it is important to either remove or inactivate 
the original tagged-cDNA primers after the cDNA reaction, and prior  
to PCR. If not, then these tagged-cDNA primers (which contain virus- 
specific sequences) can participate in the PCR reaction, just like a   
  
non-tagged virus-specific cDNA primer would. The presence of tagged
-cDNA primers in the PCR reaction therefore permits the amplification  
of false-, self- or misprimed cDNAs of the ‘wrong’ strand, leading to 
an incorrect conclusion of strand-specificity (Craggs et al., 2001; 
Peyrefitte et al., 2003; Plaskon et al., 2009; Boncristiani et al., 2009).  
Tagged-cDNA primers can be most easily removed from the cDNA 
reaction using commercial PCR/cDNA purification columns (Peyrefitte 
et al., 2003). An alternative is to use biotinylated tagged-cDNA primers 
and then capture the tagged cDNA with Streptavidin-conjugated 
magnetic beads (Boncristiani et al., 2009). Although highly effective at 
removing primers, the disadvantage of cDNA purification is that its 
DNA recovery efficiency of individual columns can be highly variable 
(Tentcheva et al., 2006), leading to different types of error in 
(quantitative) detection and interpretation. This can be managed by 
adding a passive ‘reference’ DNA prior to cDNA purification (similar in 
concept to the “exogenous internal reference standards” used in RT-
qPCR quantification, discussed in the BEEBOOK paper on molecular 
techniques; Evans et al., 2013), which can be used to normalize the 
data again afterwards.  
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10.2.5. Inactivating tagged-cDNA primers in the cDNA 
reaction 
It is also possible to inactivate the tagged-cDNA primer in the cDNA 
reaction, and so prevent it from participating in the PCR reaction. This 
can be done using exonuclease-I, which specifically digests only  
single-stranded DNA, i.e. the tagged-cDNA primer (Craggs et al., 2001; 
Purcell et al., 2006; Plaskon et al., 2009; Lin et al., 2009) or by 
phosphorylating the 3’ end of the tagged-cDNA primer (making it 
impossible for the polymerases in PCR to synthesize DNA from this 
primer). These enzymatic reactions can be done right after the cDNA 
reaction, in the same reaction tube, after which the enzymes can be 
heat-inactivated prior to the PCR reaction. The exonuclease-I 
digestion has become the method of choice for quantitative strand-
specific RT-qPCR (e.g. Purcell et al., 2006; Plaskon et al., 2009;  
Lin et al., 2009; Runckel et al., 2011). The main advantages of 
enzymatic inactivation of the tagged-cDNA primers, compared to the 
primer removal methods (see section 10.2.4.), is that enzymatic 
inactivation is much faster and cheaper, with fewer handling and 
contamination errors (no tube changes), and that it avoids the 
possible quantitation errors of the primer removal methods.  
Fig. 5. Outline of the procedure for strand-specific RT-PCR amplification of negative-strand viral RNA, using tagged-cDNA primers to avoid 
amplification of non-target cDNAs. Only cDNA produced with tagged-cDNA primers, and amplified with the tag and a virus-specific primer will 
be amplified. RdRp refers to the viral RNA-dependent RNA polymerase.                                                                  Image © JR de Miranda. 
Table 5.  Primers and tags used for detection of positive and negative strand honey bee virus RNAs by strand-specific RT-PCR.   
 
 
 
10.2.6. Dilution 
Another strategy to minimize the chance of illegitimate amplification 
of non-strand-specific cDNA molecules through the involvement of 
residual tagged-cDNA primer, is to dilute the cDNA reaction mixture 
10-fold prior to PCR (Craggs et al., 2001).  
 
10.2.7. Strand-specific real-time RT-qPCR 
Finally, a very effective way to manage the consequences of 
illegitimate priming events during cDNA synthesis is to use real-time 
qPCR for strand-specific detection (Purcell et al., 2006; Gisder et al., 
2009; Boncristiani et al., 2009; Plaskon et al., 2009; Lin et al., 2009; 
Zioni et al., 2011). This allows all the PCR products arising from rare 
cDNAs generated by false-, self- or mis-priming events to be excluded 
from the data on quantitative grounds.      
 
10.2.8. Protocols 
All these conditions can easily be incorporated into a one-tube 
protocol combining the benefits of an RT-reaction at higher 
temperature, tagged primers, exonuclease-I digestion of the tag-cDNA 
primer and dilution of the cDNA, prior to real-time qPCR with a primer 
complementary to the tag and a virus-specific forward primer. 
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10.2.8.1. High temperature reverse transcription 
Using an elevated temperature for the cDNA reaction significantly 
reduces mis-priming events, and thus the risk of falsely detecting the  
incorrect strand. Common alternatives are: SuperScript-III (50°C: 
Peyrefitte et al., 2003; Purcell et al., 2006; Plaskon et al., 2009; Lin et al., 
2009; Runckel et al., 2011), OmniScript/SensiScript (55°C: Yue and 
Genersch, 2005; Gisder et al., 2009), Thermoscript (60°C: Carrière et al., 
2006; Horsington and Zhang, 2007) and rTth reverse transcriptase 
(70°C: Lanford et al., 1995; Laskus et al., 1998; Craggs et al., 2001; 
Celle et al., 2009). The method below is a generic one, with individual 
adaptations for the different reverse transcription options:  
 
1.   Mix: 
1.1. 5 µl 50 ng/µl RNA, 
1.2. 1 µl 10 µM tagged-cDNA primer (0.5 µM final 
concentration), 
1.3. 2 µl nuclease-free water. 
2.   Heat 70°C for 5 min. Cool on ice for 2 min . 
3.a. For SuperScript-III reactions, add:  
3.a.1. 10 µl 2x SuperScript-III buffer (containing 1 mM dNTP), 
3.a.2. 2 µl SuperScript-III/RNAseOUT mixture, 
3.a.3. Incubate 30 min at 50oC, 
TAG VIRUS STRAND PRIMER SEQUENCE FUNCTION REFERENCES 
agcctgcgcaccgtgg 
DWV 
+ (pos) 
tag-B23 agcctgcgcaccgtggCCACCCAAATGCTAACTCTAAGCG tagged-cDNA 
Yue and Genersch, 2005  
Gisder et al., 2009   
Dainat et al., 2009 
F15 TCCATCAGGTTCTCCAATAACGGA virus-sense 
- (neg) 
tag-F15 agcctgcgcaccgtggTCCATCAGGTTCTCCAATAACGGA tagged-cDNA 
B23 CCACCCAAATGCTAACTCTAAGCG virus-antisense 
DWV 
+ (pos) 
tag-DWVas agcctgcgcaccgtggTCGACAATTTTCGGACATCA tagged-cDNA 
Boncristiani et al., 2009 
DWV-s ATCAGCGCTTAGTGGAGGAA virus-sense 
- (neg) 
tag-DWVs agcctgcgcaccgtggATCAGCGCTTAGTGGAGGAA tagged-cDNA 
DWV-as TCGACAATTTTCGGACATCA virus-antisense 
IAPV 
+ (pos) 
tag-IAPVas agcctgcgcaccgtggCTTGCAAGATAAGAAAGGGGG tagged-cDNA 
DiPrisco et al., 2011 
IAPV-s GCGGAGAATATAAGGCTCAG virus-sense 
- (neg) 
tag-IAPVs agcctgcgcaccgtggGCGGAGAATATAAGGCTCAG tagged-cDNA 
IAPV-as CTTGCAAGATAAGAAAGGGGG virus-antisense 
BQCV 
+ (pos) 
tag-BQCVas agcctgcgcaccgtggGCAACAAGAAGAAACGTAAACCAC tagged-cDNA 
Peng et al., 2011 
BQCV-s TCAGGTCGGAATAATCTCGA virus-sense 
- (neg) 
tag-BQCVs agcctgcgcaccgtggTCAGGTCGGAATAATCTCGA tagged-cDNA 
BQCV-as GCAACAAGAAGAAACGTAAACCAC virus-antisense 
atcggaatcgcctagctt CBPV 
+ (pos) 
tag-R23 atcggaatcgcctagcttCCCAATGTCCAAGATGGAGT tagged-cDNA 
Celle et al., 2008 
R20 GCTTGATCTCCTCCTGCTTG virus-sense 
- (neg) 
tag-R20 atcggaatcgcctagcttGCTTGATCTCCTCCTGCTTG tagged-cDNA 
R23 CCCAATGTCCAAGATGGAGT virus-antisense 
ggccgtcatggtggcgaataa    
(Plaskon et al., 2009) 
LSV-1 
+ (pos) 
tag-LSVU-R1717 ggccgtcatggtggcgaataaCCATATCATAAGTTGGCAAGTG tagged-cDNA 
Runckel et al., 2011 
LSV1-F1434 CAGGTGCAGAGCAATTGGATTCA virus-sense 
- (neg) 
tag-LSV1-F1434 ggccgtcatggtggcgaataaCAGGTGCAGAGCAATTGGATTCA tagged-cDNA 
LSVU-R1717 CCATATCATAAGTTGGCAAGTG virus-antisense 
LSV-2 
+ (pos) 
tag-LSVU-R1717 ggccgtcatggtggcgaataaCCATATCATAAGTTGGCAAGTG tagged-cDNA 
LSV2-F1434 TAGGTGTCGGGCCATAGGGTTTG virus-sense 
- (neg) 
tag-LSV2-F1434 ggccgtcatggtggcgaataaTAGGTGTCGGGCCATAGGGTTTG tagged-cDNA 
LSVU-R1717 CCATATCATAAGTTGGCAAGTG virus-antisense 
3.a.4. Inactivate 15 min at 95°C, 
3.a.5. Cool reaction to room temperature, store on ice.  
3.b. For OmniScript/SensiScript reactions, add: 
3.b.1. 4 µl 5x Qiagen OneStep RT-PCR buffer, 
3.b.2. 0.8 µl 10 mM dNTP (400 µM final concentration), 
3.b.3. 0.8 µl Qiagen OneStep enzyme mix, 
3.b.4. 5.4 µl nuclease-free water, 
3.b.5. Incubate 30 min at 50°C. Go to section 10.2.8.4. 
3.c. For ThermoScript reactions, add: 
3.c.1. 4 µl 5x ThermoScript buffer, 
3.c.2. 2 µl 10 mM dNTP (1 mM final concentration), 
3.c.3. 1 µl 0.1 M DTT (5 mM final concentration), 
3.c.4. 1 µl 40 u/µl RNAseOut, 
3.c.5. 1 µl 15 u/µl ThermoScript, 
3.c.6. 4 µl nuclease-free water, 
3.c.7. Incubate 30 min at 60°C, 
3.c.8. Inactivate 15 min at 95°C, 
3.c.9. Cool reaction to room temperature, store on ice. 
3.d. For rTth reactions, add: 
3.d.1. 2 µl 10x rTth buffer, 
3.d.2. 0.4 µl 10 mM dNTP (200 µM final concentration), 
3.d.3. 1 µl 10 mM MnCl2 (1 mM final concentration), 
3.d.4. 2 µl 2.5 u/µl rTth reverse transcriptase, 
3.d.5. 6.6 µl nuclease-free water, 
3.d.6. Incubate 30 min at 70°C, 
3.d.7. Add 2 µl 10x chelating buffer (to chelate the Mn+2), 
3.d.8. Inactivate 15 min at 98°C, 
3.d.9. Cool reaction to room temperature, store on ice.  
 
10.2.8.2. Exonuclease-I digestion of tagged primer 
Exonuclease-I specifically digests only single-stranded DNA, in a 3’-5’ 
direction, and thus inactivates unincorporated tagged-cDNA primer 
prior to PCR. This reduces ten-fold the chance of falsely detecting the 
incorrect strand (Craggs et al., 2001) and is a common step in strand-
specific RT-PCR (Purcell et al., 2006; Lin et al., 2009; Plaskon et al., 
2009; Runckel et al., 2011). 
1.   Add to the cDNA reaction: 
10 u Exonuclease-I.  
2.   Incubate 30 min at 37°C; inactivate 15 min at 70°C. 
3. Dilute cDNA reaction ten-fold, to 200 µl. 
 
10.2.8.3. Column purification of cDNA 
The cDNA can also be purified to remove unincorporated tagged-
cDNA primer, using Qiagen affinity purification columns, and thus 
significantly reduce the chance of falsely detecting the incorrect 
strand through participation of residual tagged-cDNA primer in the 
early PCR reactions. This procedure is a common alternative to 
Exonuclease-I digestion (Peyrefitte et al., 2003; Carrière et al., 2007) 
and used in strand-specific detection of several honey bee viruses 
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(Boncristiani et al., 2009; DiPrisco et al., 2011; Peng et al., 2012). 
1. Follow Qiagen DNA affinity column purification protocol. 
2. Elute the purified cDNA in 100 µl nuclease-free water.  
 
10.2.8.4. OneStep PCR 
Yue and Genersch (2005) developed a modified OneStep protocol for 
strand-specific RT-PCR that does not include specific steps to remove 
the tagged cDNA primer prior to PCR. Occasionally, weak bands are 
produced derived from non-strand-specific cDNA priming events 
(Gisder et al., 2009). 
1.   For the OmniScript/SensiScript OneStep RT-PCR reactions, 
add: 
1.1. 0.5 µl 10 µM tag primer (0.25 µM final concentration), 
1.2. 0.5 µl 10 µM virus-specific primer (0.25 µM final 
concentration). 
2.   Incubate  
 2.1. 15 min at 95°C, 
 2.2. 35 cycles of [94°C:30 sec – 54.5°C:60 sec – 72°C:30 sec], 
 2.3. 72°C:10 min. 
 
10.2.8.5. Real-time qPCR 
The SuperScript-III, Thermoscript and rTth cDNA reactions all enter a 
separate (TwoStep) PCR protocol, which can be conveniently adapted 
to real-time qPCR, using a real-time qPCR kit containing SYBR-green: 
 
1.   Mix: 
1.1. 3 μl cDNA (column purified, or diluted 1/10), 
1.2. 0.4 µl 10 μM tag primer (0.2 μM final concentration), 
1.3. 0.4 µl 10 μM virus-specific primer (0.2 μM final 
concentration), 
1.4. 0.4 µl* 10 mM dNTP* (0.2 mM final concentration*), 
1.5. x µl Buffer + SYBR-green (as per manufacturer), 
1.6. y µl nuclease-free water, 
1.7. z µl Taq polymerase (as per manufacturer), 
1.8. 20 µl total volume. 
(* dNTPs are often included in the optimized buffer) 
2.   Incubate in real-time thermocycler:  
 2.1. 5 min:95°C, 
 2.2. 35 cycles [10 sec:95°C - 30 sec:58°C - read].   
3.   For Melting Curve analysis of the products, incubate: 
 3.1. 1 min:95°C, 
 3.2. 1 min:55°C, 
 3.3. 5 sec:0.5°C:read from 55°C to 95°C.  
 
10.2.9. Controls 
By now it should be evident that strand-specific RT-PCR should 
include a large number of controls, to account for the many ways by 
which an incorrect result can be generated. Most of these involve the 
reverse transcription reaction, since this is where most of the errors 
come from. The one essential control that should be run for every 
individual sample is: 
 A primer-free cDNA reaction (proof that self-primed cDNA is 
not amplified). 
Other controls that should be included at least once for the 
experiment are: 
 A template-free cDNA reaction (absence of contamination of 
reagents/pipettes with target DNA). 
 A reverse-transcriptase-free cDNA reaction (absence of 
reverse-transcriptase activity during PCR). 
 An exonuclease-I-free cDNA reaction (disappearance of signal 
from mis-primed cDNA reactions). 
 
The PCR step for all these controls should also include tagged-cDNA 
primer, equivalent to the estimated carry-over from the cDNA 
reaction, in addition to the regular concentrations of tag primer and 
virus-specific primer necessary for the PCR. Through this, the controls 
will contain the complete primer composition of the experimental 
reactions, which (as explained above) is an essential condition for 
excluding possible false positives. 
Whether or not false-positive results during strand-specific RT-
PCR presents a major problem also depends on the question to be 
answered. If the virus replication in a certain host, tissue or cell type 
is expected, then false-positive results are not a major factor. In 
contrast, if the absolute presence or absence of replication needs to 
be proven, then extreme care must be taken when conducting and 
interpreting the experiments. 
 
10.3. Multiplex Ligation-dependent Probe 
Amplification (MLPA) 
10.3.1. Introduction 
 
 
Multiplex Ligation-dependent Probe Amplification (MLPA) technology is 
an amplification technique that allows simultaneous detection of up to 
40 targets with the use of a single PCR primer pair. The procedure 
uses a series of paired oligonucleotides (half-probes), each pair 
specific for one target. The two half-probes; the Left Probe Oligo 
(LPO) and the Right Probe Oligo (RPO) lie adjacent to each other on 
the target genome so that they can be joined together by a ligation 
reaction, to produce an amplification probe (Fig. 6). In addition to a 
target-specific sequence, each of the half-probes contains one of two 
sequences recognized by a universal PCR primer, for probe 
amplification. Since these PCR primer sequences are common to all 
half-probe pairs, a single pair of PCR primers can amplify all target 
probes in a multiplex reaction. The half-probe pairs also contain a 
‘stuffer’ fragment of variable length, allowing each amplified probe to 
be identified by its size, using (capillary) electrophoresis (Fig. 6). This 
technique was recently adopted to detect the most common honey 
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bee viruses including CBPV, DWV (KV & VDV-1), ABPV (IAPV & KBV), 
BQCV, SBPV, SBV (De Smet et al., 2012). Because these are all RNA 
viruses, the MLPA is preceded by a reverse transcription of RNA into 
cDNA. Since the probes are strand-specific, this technique is highly 
suitable for the selective detection of either the positive-strand 
genomic viral RNA or the negative-strand virus replicative 
intermediate RNA, which is a marker for virus replication. 
Since several targets are amplified at the same time, there will be 
competition between different targets for the amplification resources 
(primers, nucleotides, enzyme). This ‘competitive’ PCR allows for a 
measure of relative quantification between the targets, in the sense 
that the relative proportion of the targets after amplification should, if 
all targets amplify equally efficiently, reflect their initial proportions in 
the sample. By including one or more internal reference genes or 
exogenously added absolute quantification standards among the 
targets, the procedure can be made (semi-) quantitative.  
 
10.3.2. Protocol 
The reactions are performed in a thermocycler with heated lid (105°C) 
in 0.2 ml thin-walled PCR tubes. The specific MLPA reagents can be 
obtained from MRC-Holland. The various probes and oligonucleotides 
used in the honey bee virus MLPA are given in Table 6. It is 
recommended to use the wildtype MuMLV Reverse Transcriptase from 
Promega (M1701). The right probe oligos (RPO) are phosphorylated 
and should be synthesized as ‘ultramer’ grade. 
 
10.3.2.1. Primer and probe mixtures 
1.   Prepare RT-primer mix:  
1.1. 5 mM each dNTP, 
1.2. 5 µM each RT primer (Table 6). 
2.   Prepare probe mix:  
1.33 nM of each half-probe (Table 6) in TE(8.0) buffer. 
 
10.3.2.2. Reverse transcription 
1.   Mix on ice:  
1.1. 10~500 ng RNA, 
1.2. 1 µl SALSA RT buffer,  
1.3. 0.5 µl RT-primer mix,  
1.4. Sterile water to 4.5 µl total volume.  
2.   Incubate 1 min at 80°C. 
3.   Incubate 5 min at 45°C. 
4.   Add 1.5 µl 20 u/µL MuMLV Reverse Transcriptase.  
If necessary, dilute in 1:1 water: SALSA enzyme dilution buffer.  
5.   Mix. 
6.   Incubate: 
 6.1. 15 min at 37°C, 
 6.2. 98°C for 2 min (reverse transcriptase inactivation), 
 6.3. Cool to 25°C. 
Fig. 6. Outline of the MLPA procedure for amplifying strand-specific ligated probes. LPO and RPO refer to the Left Probe Oligo and Right 
Probe Oligo respectively. RdRp refers to the viral RNA-dependent RNA polymerase.                                                       Image © L De Smet. 
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Table 6. Primers and probes used for detection of positive and negative strand honey bee virus RNAs by MLPA. Adapted from De Smet et al. (2012). 
VIRUS STRAND PRIMER FUNCTION SEQUENCE (5'-3') SIZE (bp) 
CBPV 
+ (pos) 
LDS22 (-)cDNA GCCCCGATCATATAAGCAAA 
88 LDS23 (+)MLPA-LPO gggttccctaagggttggaCCGTAGCTGTTTCTGCTGCGGT 
LDS24 (+)MLPA-RPO P-ACTCAGCTCAGCTCGACGCTCAGAtctagattggatcttgctggcac 
- (neg) 
LDS59 (+)cDNA GAACATCCGGAACAGACGAT 
88 LDS60 (-)MLPA-LPO gggttccctaagggttggaTCTGAGCGTCGAGCTGAGCTGAGT 
LDS61 (-)MLPA-RPO P-ACCGCAGCAGAAACAGCTACGGtctagattggatcttgctggcac 
  
+ (pos) 
LDS8 (-)cDNA TCACATTGATCCCAATAATCAGA 
95   LDS9 (+)MLPA-LPO gggttccctaagggttggaTGACCGATTCTTTATGCAGCGAGCTCT 
DWV/KV LDS10 (+)MLPA-RPO P-TACGTGCGAGTCGTACTCCTGTGACAtctagattggatcttgctggcac 
VDV-1 
- (neg) 
LDS31 (+)cDNA GTGTGGTGCATCTGGAATTG 
95   LDS32 (-)MLPA-LPO gggttccctaagggttggaGTTGTCACAGGAGTACGACTCGCA 
  LDS33 (-)MLPA-RPO P-CGTAAGAGCTCGCTGCATAAAGAATCGGTtctagattggatcttgctggcac 
  
+ (pos) 
LDS1 (-)cDNA (ABPV) CAATGTGGTCAATGAGTACGG 
104 
  LDS2 (-)cDNA (KBV&IAPV) TCAATGTTGTCAATGAGAACGG 
ABPV LDS19 (+)MLPA-LPO gggttccctaagggttggaCTCACTTCATCGGCTCGGAGCATGGATGAT 
KBV LDS4 (+)MLPA-RPO P-ACGCACAGTATTATTCAGTTTTTACAACGCCCtctagattggatcttgctggcac 
IAPV 
- (neg) 
LDS62 (+)cDNA TGAAACGGAACAAATCACCA 
104   LDS63 (-)MLPA-LPO gggttccctaagggttggaCGAGCCGATGAAGTGTCTTGAGCCATGG 
  LDS64 (-)MLPA-RPO P-GGGTATTGATCCTATTTGGAGTTTCCACATCATGtctagattggatcttgctggcac 
BQCV 
+ (pos) 
LDS16 (-)cDNA CGGGCCTCGGATAATTAGA 
122 LDS21 (+)MLPA-LPO gggttccctaagggttggaCTTCATGTTGGAGACCAGGTTTGTTTGCCGACTTACGGAA 
LDS18 (+)MLPA-RPO P-TGTCGTTAAACTCTAGGCTTTCCGGATGGCTTCTTCATGGtctagattggatcttgctggcac 
- (neg) 
LDS65 (+)cDNA TTAAAAGCCCCGTATGCTTG 
122 LDS66 (-)MLPA-LPO gggttccctaagggttggaTCAGCGCAACAGAAGCCATCCGGAAAGCCTAGAGTTTAACG 
LDS67 (-)MLPA-RPO P-ACATTCCGTAAGTCGGCAAACAAACCTGCCTTATCTGGTtctagattggatcttgctggcac 
SBPV 
+ (pos) 
LDS25 (-)cDNA CGCAAACACGACGAATTTTA 
131 LDS26 (+)MLPA-LPO gggttccctaagggttggaCGTTCAATGGTCGAGATAGAAGCCACAGTAGAAGTATTACGCGCT 
LDS27 (+)MLPA-RPO P-TCTTGTGTTTTGGCTTATGGGCGTGGGCCTGATCTTCATTCAGCtctagattggatcttgctggcac 
- (neg) 
LDS68 (+)cDNA GGTGTCATAAACAGAATGACGAG 
131 LDS69 (-)MLPA-LPO gggttccctaagggttggaTCAGCGCAACACTCAGGCCCACGCCCATAAGCCAAAACACAAGAA 
LDS70 (-)MLPA-RPO P-GCGCGTAATACTTCTACTGTGGCTTCTATCTCGCCTTATCTGGTtctagattggatcttgctggcac 
SBV 
+ (pos) 
LDS28 (-)cDNA TGGACATTTCGGTGTAGTGG 
140 LDS29 (+)MLPA-LPO gggttccctaagggttggaCGTTGATCCAATGGTCAGTGGACTCTTATACCGATTTGTTTAATGGTTGG 
LDS30 (+)MLPA-RPO P-GTTTCTGGTATGTTTGTTGACAAGAACGTCCACCTTCAGCCATTCAGCtctagattggatcttgctggcac 
- (neg) 
LDS71 (+)cDNA CCTTACCTCTAGTAAGAAGACATTTGA 
140 LDS72 (-)MLPA-LPO gggttccctaagggttggaTAAAAAACTACCGTGTAGTGGACGTTCTTGTCAACAAACATACCAGAAA 
LDS73 (-)MLPA-RPO P-CCCAACCATTAAACAAATCGGTATAAGAGTCCACTGAAAAGTCGGTGGAtctagattggatcttgctggcac 
β-Actin + (pos) 
LDS58 (-)cDNA TTTCATGGTGGATGGTGCTA 
182 LDS56 (+)MLPA-LPO 
gggttccctaagggttggaGCAGGAAGTCGTTACCACCTGGCCCAC-
GGAGCCAATTTCTCATGCTTGCCAACACTGTCCTTTCTGGAGGT 
LDS57 (+)MLPA-RPO 
P- ACCACCATGTATCCTGGAATCGCGAAAACGTGGTGTACCGGCTGTCTGGTATGTATGAG-
TTTGTGGTGAtctagattggatcttgctggcac 
PCR 
LDS11 PCR-Forward gggttccctaagggttgga 
n.a. 
LDS12 PCR-Reverse gtgccagcaagatccaatctaga 
10.3.2.3. Hybridisation of MLPA half-probes 
1.   Add to the reverse transcription reaction and mix with care: 
1.1. 1.5 µl Probe-mix,  
1.2. 1.5 µl MLPA buffer.  
2.   Incubate: 
 2.1. 1 min at 95°C, 
 2.2. 16 h at 60°C in a PCR ThermoCycler. 
 
10.3.2.4. Ligation of MLPA half-probes 
1.   Reduce the temperature of the thermal cycler to 54°C.  
2.   While at 54°C, add to each sample: 
2.1. 3 µl Ligase-65 buffer A, 
2.2. 3 µl Ligase-65 buffer B, 
2.3. 25 µl sterile water,  
2.4. 1 µl Ligase-65. 
3.   Mix well. 
4.   Incubate: 
 4.1. 10-15 min at 54°C, 
 4.2. 5 min at 98°C (inactivation of Ligase-65). 
5.   Cool on ice. 
 
 
10.3.2.5. PCR amplification of MLPA probes 
1.   Mix in new tubes:  
1.1. 10 µl MLPA ligation reaction, 
1.2. 4 µl SALSA PCR buffer, 
1.3. 26 µl sterile water. 
2.   While the tubes are in the thermal cycler at 60°C, add to each 
tube:  
2.1. 2 µl SALSA PCR primers, 
2.2. 2 µl SALSA enzyme dilution buffer,  
2.3. 5.5 µl sterile water, 
2.4. 0.5 µl SALSA polymerase.  
3.   Incubate: 
 3.1. 35 cycles [30 sec:95°C - 30 sec:60°C - 60 sec:72°C], 
 3.2. 20 min:72°C. 
 
10.3.3. Fragment analysis 
The MLPA reaction products can be analysed on conventional slab 
electrophoresis, using a 4% agarose-TBE gel (De Smet et al., 2012; 
Green and Sambrook, 2012), or using a high-resolution, semi-
automatic electrophoresis system such as the BioAnalyzer (Aligent), 
Experion (Biorad), Qiaxcel (Qiagen) or MultiNA (Shimadzu), which are 
designed for separating short fragments. In all cases, interpretation of 
the results is simplified by loading a specific MLPA ladder, generated 
amplifying each of the MLPA targets individually from cloned controls 
and pooling these into a single ladder. 
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Agarose gel electrophoresis: 
1.   Prepare a 4% high resolution agarose gel in 1x TRIS-Borate-
EDTA buffer (Green and Sambrook, 2012). 
2.   Mix: 
 2.1. 10 µl aliquot of the MLPA reaction, 
 2.2. 5 µl 4x Sample Buffer. 
3.   Load gel. 
4.   Run for 45-60 minutes at 75-90 volts. 
 
Semi-automatic high-resolution gel electrophoresis: 
1.   Use gel system appropriate for 25-500 bp DNA fragments. 
2.   Follow manufacturers’ instructions for sample preparation, 
loading, running and data analysis. 
 
10.3.4. Controls 
As for strand-specific RT-PCR, MLPA requires a large number of 
controls to rule out the possibility of artefactual results due to the 
methods used.  
 
 A nucleic acid-free control (the two half-probes should not be 
able to ligate without a template). 
 A reverse transcriptase-free control (the two half-probes 
should not be able to ligate on an RNA template). 
 A cDNA primer-free control (identifies possible self-priming of 
RNA for cDNA synthesis). 
 A half-probes-free control (only the two half-probes should 
generate an amplifiable template for PCR). 
 A ligase-free control (the two half-probes should not be able 
to ligate without ligase0. 
 A PCR primer-free control (the two half-probes should not be 
able to function as PCR primers either with each other or with 
the cDNA primer). 
 
 
11. Virus variation 
11.1. Introduction 
Due to the importance of genetic variability to virus virulence and 
evolution, the detection and quantification of virus genetic variability 
as a trait in itself has been an interest throughout the history of virus 
research. Throughout the history of molecular diagnostics, new 
technologies have been adapted for the detection and quantification 
of polymorphisms or genetic variation, reviewed by Ahmadian and 
Lundeberg (2002). Below are a few of the more current methods.  
 
 
 
11.2. Protocols 
11.2.1. Nuclease protection assays (RPAs and SNPAs) 
Nuclease protection assays are an efficient way to analyse the genetic 
complexities of natural populations of organisms (Kurath et al., 1993; 
Arens, 1999; Wang and Chao, 2005). A labelled probe is hybridised to 
the nucleic acid sample of a population of organisms (usually viruses 
or other pathogens, sometimes related mRNA species) and then 
digested with RNAse (RNA probe) or S1-nuclease (DNA probe) which 
will cut the probe wherever there is a mismatch between probe and 
target. The resulting pattern of digested probe fragments, revealed by 
gel electrophoresis, is qualitatively and quantitatively indicative of the 
mismatch polymorphisms present in the nucleic sample. These 
procedures are called RNAse Protection Assay (RPA) and S1-Nuclease 
Protection Assay (SNPA).  
 
Pros: Entire populations can be screened for genetic complexity 
within the target sequence in a single reaction. The polymorphic 
sites can be mapped on the genome, through the sizes of the 
fragments produced.  
Cons: Assay is limited to about 300 bases, requiring many assays 
to cover a genome. Protocols are complex and subject to errors. 
The nature of the polymorphs requires further analysis. 
 
11.2.2. Gel retardation assays (SSCP and DGGE) 
Single Strand Conformation Polymorphism (SSCP) and Denaturing 
Gradient Gel Electrophoresis (DGGE) are two techniques that use 
electrophoresis to differentiate directly between variants in a 
population of sequences (Hauser et al., 2000; Stach et al., 2001). In 
SSCP the nucleic acids are made single-stranded, to fold into a 
preferred secondary structure. In DGGE, the nucleic acids are 
separated in an electrophoretic gel containing a salt gradient that will 
progressively denature the nucleic acids. In both methods, minor 
nucleotide differences between polymorphs in the population affect 
the migration of the DNA. Another technique with a similar philosophy 
is the heteroduplex mobility shift assay, where single nucleotide 
mismatches between a probe and target affect the mobility of the 
hybridised complex during electrophoresis, (Arens, 1999).  
 
Pros: Entire populations can be screened for genetic complexity 
within the target sequence in a single reaction. 
Cons: Assay is limited to about 300 bases, requiring many assays 
to cover a genome. Protocols are complex, sensitive to procedural 
accuracy and subject to errors. The nature of the polymorphs 
requires further analysis. 
 
11.2.3. High Resolution Melting (HRM) analysis 
Double stranded DNA can disassociate (or melt) into two single 
strands upon heating, and can re-associate (or hybridize) upon 
cooling, in a highly predictable fashion. This fundamental property of  
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nucleic acids underpins all nucleic acid technologies. The principal 
parameters governing disassociation/hybridization are the length and 
composition of the DNA, the temperature and the salt concentration 
of the solution. Work in the 1950s demonstrated that the G-C pairing, 
with three hydrogen bonds, gave higher thermal stability than the A-T 
pairing, which has only two such bonds (Marmur and Doty, 1959). 
This made it possible to predict the temperature at which a DNA 
molecule would melt (Tm) from its length and base pair composition 
(Marmur and Doty, 1962). The discovery of DNA binding dyes such as 
SYBR-green, that fluoresce only when intercalated with double 
stranded but not single stranded molecules, provided a practical 
method to quantify the melting process based on a reduction in 
fluorescence during gradual heating, as the two DNA strands 
separated. This fluorescence-based detection was integrated with real
-time PCR thermocyclers that can very precisely control the 
temperature of a DNA sample and collect fluorescence data between 
10 and 200 times per °C, providing high-resolution melting curves 
that can distinguish single base pair differences between two PCR 
products (Wittwer et al., 2003). This makes it possible to use High 
Resolution Melting (HRM) analysis to analyse the composition of 
mixed samples, i.e. samples containing two or more genetic variants 
of the same region, by comparing the melting curve of the mixed 
sample with those of the individual variants.   
HRM analysis is a versatile method that can be applied to any 
sample that contains double stranded DNA, including cDNA or PCR 
products. The flexibility of HRM analysis has led to a diverse array of 
applications including pre-sequence screening, Single Nucleotide 
Polymorphism (SNP) typing, methylation analysis, microsatelite or 
Simple Sequence Repeat (SSR) marker screening (Arthofer et al., 2011) 
and copy number quantification. Several of these techniques are 
covered in the BEEBOOK paper on molecular techniques (Evans et al., 
2013). Such applications of HRM are also relevant to virology, and the 
first record of a virological use of HRM analysis was to strain type 
West Nile virus (Papin et al., 2004). Recently, HRM analysis has been 
used to monitor the relationship between varroa infestation and virus 
diversity (Martin et al., 2012).  
Many standard real-time PCR machines can be used for HRM 
analyses. Often an upgrade of the software package and the running 
of a calibration plate is all that is required to enable a real-time PCR 
machine to run HRM analyses. Since HRM is a highly technical and 
sensitive procedure that integrates reaction biochemistry with 
machinery and analysis software, the best advice is to follow the 
protocol, reagents and incubation profile recommended by 
manufacturer. The basic procedure is as follows:  
 
1.   Amplification: Amplify your chosen fragment from your 
experimental samples and cloned controls, using specific HRM 
reagents containing a saturating DNA DNA intercalating dye 
and the recommended incubation profile.   
Fig. 7.  Mixed virus sequences as revealed in sequence electropherogram. 
The mixed sequence can be resolved into component sequences using 
specifically designed software. Adapted from Forsgren et al., 2009.  
2.   Replicates: Use a minimum of three technical replicates for 
each sample. The replicate melting profiles will be averaged 
and used to assess whether the sample is distinct from other 
samples/controls. 
3.   HRM: Immediately after amplification the PCR products are  
 subjected to a high-resolution melting step, within the same 
tube, during which the decrease in fluorescence due to the 
transition of the DNA from double- to single-stranded shape is 
monitored. 
4.   Analysis: The melting curve of the experimental sample, 
containing a mixture of different variants, is compared to the 
melting curves of pure, cloned versions of each of the 
individual variants.    
 
Pros: Simple; fast; flexible; cheap; sensitive; specific; low  
 contamination risk. 
Cons: Requires individual melting curves of (cloned) variants. 
 Cannot identify nature of novel variants. Limited quantification of 
variants. Limited capacity to resolve complex mixture. Limited to 
very short genome fragments.   
  
11.2.4. Sequencing 
The most powerful means for detecting variation is sequencing, since 
every possible variant is identified and precisely mapped on the 
genome. There are several approaches that can be used. The purest 
and most expensive approach is to clone PCR products of the target(s) 
and sequence batches of individual clones. This also allows the 
relative frequencies of individual variants to be determined, even 
those variants occurring at very low frequencies. A second and 
cheaper approach is to sequence the PCR products directly and 
identify the polymorphisms at sites of ambiguity in the sequence 
(Forsgren et al., 2009; Fig. 7). Since such double peaks can also be 
the result of sequencing artefacts, each polymorphic site has to be 
confirmed by a matching pattern when sequencing the complementary 
strand. Only major polymorphisms can be identified and quantitation 
is moderate, similar to HRM. The new, high volume automated 
sequencing methods (Next Generation Sequencing, or NGS) have the 
capacity to directly analyse complex DNA and RNA mixtures through 
sequencing followed by automated similarity searches. These methods 
are rapidly becoming cheaper and more accurate, mostly through 
massive multiplexing of reactions and samples. They are increasingly 
being used as a one-step diagnostic method capturing millions of 
different targets, thus benefiting also from economy of scale in the 
data generated. They have recently also been used in honey bee 
pathology studies (Cox-Foster et al., 2007; Runckel et al., 2011) and 
are covered in detail in the BEEBOOK paper on molecular techniques 
(Evans et al., 2013). 
 
40 de Miranda et al. 
Pros: Comprehensive; fast; flexible; accurate; sensitive; specific; 
low contamination risk; approximate quantification (NSG). 
Cons: Expensive - precise - limited quantification (Sanger  
sequencing); Very expensive - approximate quantification (NGS).  
 
  
12. Quality control 
12.1 Introduction 
Standardization of the diagnostic methods for detecting and 
quantifying bee viruses and of the interpretation of the results is the 
first requirement for improved harmonization of the data collected by 
different laboratories. The protocols and assays for different animal 
diseases registered with the World Organization for Animal Health 
(OIE; previously the Office International des Epizooties) ensure the 
global harmonization and standardization of detection methodologies. 
Moreover, the OIE provides criteria for the technical requirements and 
quality management in veterinary testing laboratories, in the form of a 
series of standards and recommendations that each laboratory should 
address in the design and maintenance of its quality management 
program. Valid laboratory results are essential for diagnosis, obtained 
by the use of good management practices, validated protocols and 
calibration methods as described in the ISO/IEC 17025 International 
Standard. By following these standards, a laboratory is able to obtain 
accreditation, linked to the international certification standard ISO 
9001. OIE guidelines provide an interpretation of the ISO/IEC 17025 
guidelines in the context of veterinary laboratories working with 
infectious diseases, including the validation of diagnostic assays, the 
production of international reference standards and laboratory 
competence testing. The European reference laboratory for honey bee 
diseases at ANSES in France is developing a set of standard diagnostic 
procedures for honey bee viruses, following these procedures and 
criteria.  
 
 
 
12.2. Assay selection and validation 
Full validation of molecular techniques, as per guidelines issued by the 
World Organization for Animal Health (OIE) is a relatively new concept 
in the field of honey bee virus diagnosis. In general terms, a 
diagnostic protocol is designed in response to a particular diagnostic 
need and this is then developed into an optimized, documented and 
fixed procedure, using a series of intra-laboratory validation steps that 
demonstrate the reliability of results and the performance of the 
method. Recently, a new standard (XP U47-600) was developed by 
the French Standards Institute (AFNOR) concerning the minimum 
requirements for the development, validation and implementation of 
veterinary PCR-based diagnostic methods in animal health, based on 
the recommendations by the OIE and following the ISO/IEC 17025 
criteria (NF, 2005; OIE, 2010). The validation procedure establishes 
the performance characteristics for each test method, such as 
sensitivity, specificity, detection and/or quantification limits. 
The initial validation of a RT-qPCR assay involves two steps. The 
first concerns the validation of the qPCR assay itself, in terms of: 
 
1.   Analytical specificity. 
2.   The PCR detection limit (DLPCR). 
3.   The PCR quantification limit (QLPCR).  
4.   The linearity and efficiency of the qPCR assay. 
 
The second step concerns the evaluation of the entire diagnostic 
protocol in terms of: 
 
1.   The method’s detection limit (DLmethod). 
2.   The diagnostic specificity and sensitivity on samples of known 
 status. 
3.   The method’s quantitation limit (QLmethod) based on a 
 validation range and accuracy profile.  
 
In each of the two steps, various performance parameters are 
calculated, including measurement uncertainty (MU), deviations of 
repeatability and intermediate reliability. 
The following is a step-by-step outline of how to develop an 
accredited RT-qPCR assay for the detection and quantitation of honey 
bee viruses, based on the successful development of such an assay 
for CBPV (Blanchard et al., 2012).  
 
12.2.1. Analytical specificity 
12.2.1.1. Analysis in silico 
Multiple nucleic acid sequences of the virus, obtained from public sequence 
databases and from a diverse range of biological and geographic 
sources, are compared in silico with each other and unrelated viruses 
using BLAST (Basic Local Alignment Search Tool; Altschul et al., 
1990), to identify regions of variability and conservation. See also the 
BEEBOOK paper on molecular techniques (Evans et al., 2013). 
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A series of possible diagnostic assays are designed using bioinformatics 
tools, based on the particular diagnostic requirements for the method.  
 
12.2.1.2. Experimental specificity 
The specificity of the PCR assay is then tested experimentally, using 
inclusivity and exclusivity tests. 
 Inclusivity tests  
Inclusivity tests assess the robustness of an assay, i.e. its 
ability to detect genetically diverse isolates. The PCR assay is 
evaluated against a panel of samples representing the full 
range of genetic diversity of the virus in question. This 
diversity is determined beforehand through phylogenetic 
analysis of bio-geographic isolates (see section 12.2.1.1.).  
 Exclusivity tests 
Exclusivity tests assess the specificity of an assay, i.e. its 
ability to detect only the virus in question, and not any other 
viruses. The PCR assay is evaluated against a panel of viruses 
unrelated to the virus being tested, but which are found in the 
same environment or ecological area as the virus being tested.  
 
12.2.2. PCR detection limit 
The detection limit of a qPCR assay is the lowest number of nucleic 
acid targets in a given template volume that can be detected in at 
least 95% of replicate assays. The detection limit is established by 
performing at least three independent trials, each with trial consisting 
of three independent two-fold serial dilutions of a template of known 
concentration. At each dilution level in each serial dilution series, eight 
replicate qPCR assays are run, i.e. a total of 24 replicate assays at 
each dilution level. The detection limit is the highest dilution level  
(i.e. lowest amount of target nucleic acid template) giving at least 23 
positive results from the 24 assays (95% of the replicates). 
 
12.2.3. qPCR dynamic range and quantitation limit 
PCR is an exponential (i.e. logarithmic) amplification process that is 
extremely consistent (i.e. predictable) over the entire reaction (35~40 
cycles) and over a large range of initial target concentrations (at least 
106-fold). This dynamic range and the quantitation limits of qPCR are 
determined using a 10-fold serial dilution series of known 
concentrations of (cloned) target DNA. A standard calibration curve is 
generated by linear regression of the quantification cycle (Cq) at which 
the PCR product is detected vs. the log10[target copy number]. The 
resulting algebraic equation:  
 
Cq = a * log10[target] + b   
(where ‘a’ is the slope and ‘b’ the intercept) 
 
is then used to estimate the amount of target in a sample, given the 
Cq value (Bustin et al., 2009). For accurate calibration of the curve 
and determining the error associated with data conversion, at least 
three independent trials of three independent 10-fold serial dilutions 
should be run. For each series and trial, the known amounts of target 
in each dilution are compared to the theoretical amounts estimated 
from the calibration curve, to obtain the individual bias, which is the 
averaged for all series and trials to obtain the mean bias (mb) at each 
dilution (an example is shown in Table 7). These values are then used 
to calculate the standard deviation of the obtained values (SD), and 
the uncertainty of the linearity is obtained by the formula ULINi = 2[√ 
SD² + mb²]. The combined linearity uncertainly is defined for the 
entire calibration range by the formula ULIN = │√ ΣULINi
2 / k│ where k 
is the number of dilution levels. The quantitation limit of the assay is 
then set at the target concentration of the calibration range.  
 
12.3. Method validation 
12.3.1. Method detection limit 
The method detection limit (DLmethod) is the lowest amount of 
biological target in a sample that can be detected by the entire 
method (from processing through RT-qPCR). The DLmethod is evaluated 
with biological reference samples obtained by spiking virus-free bee 
homogenates with known amounts of purified virus. At least two 
independent trials must be performed on two independent two-fold 
serial dilutions, with four replicate RNA extractions at each dilution 
level. The DLmethod is the last dilution at which viral RNA can be 
detected in all replicates (100% frequency). 
 
12.3.2. Method diagnostic sensitivity and diagnostic 
specificity  
The diagnostic specificity and sensitivity is assessed on complete 
method analysis (processing through assay) of biological samples of 
known virus status (positive or negative). Diagnostic sensitivity is 
determined by the percentage of positive results among the known 
positive samples. Diagnostic specificity is determined by the 
percentage of negative results among the known negative samples. 
 
12.3.3. Method quantitation limit and accuracy profile  
The assessment of a method’s quantitation limit is based on the 
construction and interpretation of an accuracy profile to estimate the 
precision and reliability of the values. Three independent trials must 
be performed on three independent 10-fold serial dilutions, including 
two replicate RNA extractions for each level of dilution. For each 
dilution series and each target amount, various parameters are 
determined from estimated target amounts, such as the inter-series 
variance and the repeatability variance, the sum of both giving the 
reliability variance. The standard deviation of the reliability (SDrl) is 
then obtained by the square root of the reliability variance. The mean 
bias is determined (difference between the theoretical value and the 
mean of the observed values). To construct the accuracy profile, the 
lower and upper tolerance interval limits of the quantitation method 
are determined using the following formula:  
 
mean bias +/- 2 × SDrl 
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and compared to the acceptability limits defined by the laboratory, 
e.g.  +/- 0.5 log10 (Blanchard et al., 2012). The tolerance interval 
limits of the accuracy profile have to be within the acceptability limits, 
validating the method for the thus defined calibration range. The 
quantitation limit of the method is then determined by the first level 
load of the validated calibration range. An example of the confidence 
and acceptability limits of an RT-qPCR calibration curve is given Fig. 8, 
where the evaluated method is validated for a calibration range 
between 103 and 106 copies, with a quantitation limit of 103 copies. 
 
12.4. Laboratory Validation 
The final validation of a diagnostic method is through inter-laboratory 
proficiency tests, to evaluate the reproducibility and the overall uncertainty 
of the method, and to assess performance of other laboratories to 
conduct specifically this method (Birch et al., 2004; Valentine-Thon  
et al., 2001; Verkooyen et al., 2003). To achieve this, candidate 
laboratories must submit to a training and accreditation programme.  
 
12.4.1. Training and accreditation 
The International Laboratory Accreditation Cooperation (ILAC) is an 
international cooperation of laboratory and inspection accreditation 
bodies created more than 30 years ago. It has published specific 
requirements and guides for laboratories and accreditation bodies. 
Under the ILAC system, ISO/IEC 17025 is to be used for accreditation. 
This procedure attests for the laboratory’s technical competence and 
the reliability of its results. In each country, a sole national 
accreditation body is designated, as the French Accreditation 
Committee (COFRAC) in France, the Deutsche Akkreditierungsstelle 
GmbH (DAssK) in Germany or the Swedish Board for Accreditation 
and Conformity Assessment (SWEDAC) in Sweden. Performance of 
the method must thus be validated according to the OIE or AFNOR 
standards and approved by the national accreditation committee of 
each country. Furthermore, inter-laboratory proficiency tests should 
be carried out to evaluate the reproducibility of the method.  
 
12.4.2. Inter-laboratory proficiency testing 
The basic purpose of proficiency testing is to assess performance of 
laboratories in conducting specific method. Proficiency testing provides 
an opportunity to have an independent assessment of each laboratory’s 
data compared to reference values or to the performance of other 
laboratories (e.g. Apfalter et al., 2002). The participation of the 
laboratory to proficiency testing programs assesses if the laboratory’s 
performances is satisfactory. In case of any potential problems within 
the laboratory, investigations to detect the difficulties are required. In 
order to successfully run proficiency test programs, the production and 
the distribution of reference materials (positive control, extraction 
control) are key points, as well as technical trainings of laboratories if 
necessary. In this framework, data harmonization could contribute to 
a better understanding of honey bee diseases and to a better 
diagnosis of pathological issues. 
Fig. 8. Example of the mean bias, confidence interval, acceptability 
limits and quantitation limit for a RT-qPCR calibration curve.  
After Blanchard et al., 2012.  
Table 7. Worked example of the estimation of primary and secondary 
statistics relating to the accuracy and confidence limits of a qPCR  
calibration curve. After Blanchard et al., (2012). 
 
 
 
 
 
 
 
 
 
 
 
13. Future perspectives 
The future is bright for disease diagnosis and pathogen detection. The 
molecular biology revolution of the past quarter century has matured 
through the experimental, labour driven phase to high volume 
automated systems delivering reliable, high quality information. The 
revolution is likely to continue, with new methods being developed 
annually, increasing the options available to the diagnostic virologist. 
In the 1960’s, 70’s and 80’s the development of semi-automated, 
sensitive serological assays precipitated a similar revolution in 
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pathogen detection that made more insightful research into disease 
and epidemiology possible. The most pioneering honey bee virology 
revelations were made during this time, in particular the discovery 
and serological characterisation of most of the honey bee viruses that 
we know today. Several of these remain to be characterised at the 
nucleic acid level. The development of cheap, high throughput mass 
sequencing of genomes and transcriptomes has overtaken these 
efforts somewhat, leading to the identification of novel viral nucleic 
acid sequences in bee and mite samples that may very well represent 
the genomes of viruses that had already been discovered previously. 
Matching these historical virus discoveries and their serological data to 
these nucleic acid genomes is therefore an important and urgent task, 
to avoid confusion in bee virus classification and to make sure that the 
historical literature on these viruses remains relevant in the current 
molecular age.  
The principal criteria for an ideal diagnostic system are sensitivity, 
accuracy, reliability, universality, simplicity, speed and cost. Most 
modern detection technologies are now sensitive enough to detect 
down to a single target molecule. This means that any future development 
will increasingly focus on quantitative detection (depending on the 
diagnostic requirements), with a concomitant change to a more integrated, 
quantitative disease management style. Accuracy of detection at the 
molecular level (and virus detection is largely molecular) depends 
essentially on the nature of the primary molecular recognition event, 
i.e. the interaction between target and probe. In this regard, nucleic 
acid-based detection has a considerable advantage over serological 
detection, since the kinetics of nucleic acid hybridisation is much more 
predictable and reliable than that of protein interactions. This also 
makes nucleic acid-based detection much more adaptable to changing 
requirements due to the discovery or emergence of new virus 
variants. The principal area of concern for molecular virus detection is 
reliability, i.e. avoiding misdiagnosis due to false-positive or false-
negative results. The nucleic acid genomes of viruses are naturally 
highly variable and can evolve very quickly, while current molecular 
diagnostic methods are highly sensitive to minor variations in the 
nucleic acid target, making it prone to possible false-negative errors. 
This sensitivity is largely linked to the enzymes used for molecular 
detection and future developments in molecular virus diagnostics may 
therefore increasingly feature enzyme-free technologies (Liepold  
et al., 2005). 
The variability of virus genomes is an important component of a 
virus’ adaptive response. It is in many ways a defining and unique 
characteristic for individual viruses. Other areas of virology now 
distinguish which viral forms offer increased pathogenicity, or which 
spread more easily. New methods that can directly describe and 
quantify this variability, such as HRMC, may become increasingly 
important in honey bee virology to clarify how the interactions 
between host factors, individual variants, combinations of variants or 
the variability as a whole, can induce a diseased state. 
Target amount  
(copies/reaction) 30 300 3000 30000 
Theoretical value Log10 (Tv) 1.477 2.477 3.477 4.477 
Measured value Log10 (Mv) 1.426 2.524 3.539 4.420 
  1.490 2.443 3.507 4.469 
  1.462 2.475 3.528 4.444 
  1.492 2.439 3.509 4.468 
  1.494 2.435 3.511 4.468 
Bias (Mv - Tv) -0.052 0.046 0.062 -0.057 
  0.013 -0.034 0.030 -0.009 
  -0.016 -0.002 0.051 -0.033 
  0.014 -0.038 0.032 -0.009 
  0.017 -0.043 0.034 -0.009 
Sum of Mv 7.363 12.316 17.594 22.270 
Mean Mv 1.473 2.463 3.519 4.454 
Mean bias -0.005 -0.014 0.042 -0.023 
Standard deviation of Mv 0.029 0.037 0.014 0.022 
ULINi 0.060 0.080 0.088 0.063 
ULINi² 0.004 0.006 0.008 0.004 
ULIN 0.074 
Disease is the result of a breakdown in a host’s normal physiological 
state due to the presence or proliferation of a pathogenic agent. The 
simpler component of this interaction is the pathogen, and its 
detection. Future developments however, will increasingly focus on 
the host component of disease and the interplay between pathogen 
and host. This means that future technological direction in disease 
diagnosis will emphasise multiplexing, miniaturisation (Fiorini and 
Chui, 2005) and automation (Service, 2006; Belák et al., 2009), to 
provide epigenetic data to better understand how the breakdown in 
the homeostasis between host and pathogen results in disease. Such 
information is important, since it can inform disease prevention, 
treatment and potential cures.  
Finally, automation and increased demand for simpler, faster and 
cheaper technologies for routine diagnosis with wide applicability in 
low-tech settings (Higgins et al., 2003; Schaad et al., 2003) will 
ultimately drive the costs down to where disease surveillance and 
routine monitoring becomes cost-effective (Service, 2006), even in 
low priority areas like honey bee pathology. 
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